title: Reglamento (CE) nº 2692/98 de la Comisión de 14 de diciembre de 1998 por el que se modifica el anexo II del Reglamento (CEE) nº 2377/90 del Consejo por el que se establece un procedimiento comunitario de fijación de los límites máximos de residuos de medicamentos veterinarios en los alimentos de origen animal (Texto pertinente a los fines del EEE)

eurovoc_concepts:
animal product
food inspection
public health
veterinary drug
veterinary legislation
waste

text: 15. 12. 98 ES Diario Oficial de las Comunidades Europeas L 338/5 REGLAMENTO (CE) No 2692/98 DE LA COMISI(cid:222)N de 14 de diciembre de 1998 por el que se modifica el anexo II del Reglamento (CEE) no 2377/90 del Consejo por el que se establece un procedimiento comunitario de fijaci(cid:155)n de los l(cid:146)mites m(cid:145)ximos de residuos de medicamentos veterinarios en los alimentos de origen animal (Texto pertinente a los fines del EEE) LA COMISI(cid:222)N DE LAS COMUNIDADES EUROPEAS, Visto el Tratado constitutivo de la Comunidad Europea, Visto el Reglamento (CEE) no 2377/90 del Consejo, de 26 de junio de 1990, por el que se establece un procedi- miento comunitario de fijaci(cid:155)n de los l(cid:146)mites m(cid:145)ximos de residuos de medicamentos veterinarios en los alimentos de origen animal (1), cuya (cid:156)ltima modificaci(cid:155)n la consti- tuye el Reglamento (CE) no 2686/98 de la Comisi(cid:155)n (2), y, en particular, sus art(cid:146)culos 6, 7 y 8, Considerando que, seg(cid:156)n el Reglamento (CEE) no 2377/ 90 deben establecerse progresivamente l(cid:146)mites m(cid:145)ximos de residuos para todas las sustancias farmacol(cid:155)gicamente activas que se usan en la Comunidad en medicamentos veterinarios destinados a la administraci(cid:155)n a animales productores de alimentos; Considerando que los l(cid:146)mites m(cid:145)ximos de residuos deben establecerse solamente tras examinar en el Comit(cid:130) de medicamentos veterinarios toda informaci(cid:155)n pertinente que se refiera a la inocuidad de los residuos de la sustancia en cuesti(cid:155)n para el consumidor de productos alimenticios de origen animal y la repercusi(cid:155)n de los residuos en el tratamiento industrial de productos alimen- ticios; Considerando que al fijar l(cid:146)mites m(cid:145)ximos de residuos de medicamentos veterinarios en los alimentos de origen animal es necesario especificar las especies animales en las que pueden estar presentes los residuos, los niveles que pueden estar presentes en cada uno de los tejidos pertinentes obtenidos del animal tratado (tejido diana) y la naturaleza del residuo que es importante para la vigilancia de los residuos (residuo marcador); fijarse tambi(cid:130)n l(cid:146)mites m(cid:145)ximos de residuos para el m(cid:156)sculo y la grasa; Considerando que, en el caso de medicamentos veterina- rios destinados a su uso en aves de puesta, animales lactantes o abejas productoras de miel, deben tambi(cid:130)n fijarse l(cid:146)mites m(cid:145)ximos de residuos para los huevos, la leche o la miel; Considerando que debe incluirse sulfato de manganeso, ribonucleato de manganeso, pidolato de manganeso, (cid:155)xido de manganeso, glicerofosfato de manganeso, gluco- nato de manganeso, cloruro de manganeso y carbonato de manganeso en el anexo II del Reglamento (CEE) no 2377/90; Considerando que debe permitirse un per(cid:146)odo de sesenta d(cid:146)as antes de la entrada en vigor del presente Reglamento a fin de permitir a los Estados miembros que hagan cualquier tipo de ajuste que sea necesario en las autoriza- ciones de comercializaci(cid:155)n de los medicamentos veterina- rios de que se trata, otorgadas de acuerdo con la Directiva 81/851/CEE del Consejo (3), cuya (cid:156)ltima modificaci(cid:155)n la constituye la Directiva 93/40/CEE (4), teniendo en cuenta las disposiciones del presente Reglamento; Considerando que las medidas previstas en el presente Reglamento se ajustan al dictamen del Comit(cid:130) perma- nente de medicamentos veterinarios, HA ADOPTADO EL PRESENTE REGLAMENTO: Art(cid:146)culo 1 El anexo II del Reglamento (CEE) no 2377/90 quedar(cid:145) modificado tal como se dispone en el anexo del presente Reglamento. Considerando que, para facilitar el control de rutina de los residuos, previsto en la legislaci(cid:155)n comunitaria pertinente, se fijar(cid:145)n normalmente l(cid:146)mites m(cid:145)ximos de residuos en los tejidos diana de h(cid:146)gado y ri(cid:157)(cid:155)n; que frecuentemente el h(cid:146)gado y el ri(cid:157)(cid:155)n se eliminan de las reses muertas some- tidas a comercio internacional y que, por lo tanto, deben Art(cid:146)culo 2 El presente Reglamento entrar(cid:145) en vigor el sexag(cid:130)simo d(cid:146)a siguiente al de su publicaci(cid:155)n en el Diario Oficial de las Comunidades Europeas. (1) DO L 224 de 18. 8. 1990, p. 1. (2) DO L 337 de 12. 12. 1998, p. 20. (3) DO L 317 de 6. 11. 1981, p. 1. (4) DO L 214 de 24. 8. 1993, p. 31. L 338/6 ES Diario Oficial de las Comunidades Europeas 15. 12. 98 El presente Reglamento ser(cid:145) obligatorio en todos sus elementos y directamente aplicable en cada Estado miembro. Hecho en Bruselas, el 14 de diciembre de 1998. Por la Comisi(cid:155)n Martin BANGEMANN Miembro de la Comisi(cid:155)n El anexo II del Reglamento (CEE) no 2377/90 se modificar(cid:145) como sigue: 2. Componentes org(cid:145)nicos ANEXO Sustancia farmacol(cid:155)gicamente activa Especie animal Otras disposiciones «Tri(cid:155)xido de dimanganeso Carbonato de manganeso Cloruro de manganeso Gluconato de manganeso Todas las especies productoras de alimentos (cid:230)nicamente para uso oral Todas las especies productoras de alimentos (cid:230)nicamente para uso oral Todas las especies productoras de alimentos (cid:230)nicamente para uso oral Todas las especies productoras de alimentos (cid:230)nicamente para uso oral Glicerofosfato de manganeso Todas las especies productoras de alimentos (cid:230)nicamente para uso oral (cid:222)xido de manganeso Pidolato de manganeso Todas las especies productoras de alimentos (cid:230)nicamente para uso oral Todas las especies productoras de alimentos (cid:230)nicamente para uso oral Ribonucleato de manganeso Todas las especies productoras de alimentos (cid:230)nicamente para uso oral Sulfato de manganeso Todas las especies productoras de alimentos (cid:230)nicamente para uso oral» 1 5. 1 2. 9 8 E S D i a r i o O f i c i a l d e l a s C o m u n i d a d e s E u r o p e a s L 3 3 8 / 7


title: Regulamento (CE) nº 2692/98 da Comissão de 14 de Dezembro de 1998 que altera o anexo II do Regulamento (CEE) nº 2377/90 do Conselho, que prevê um processo comunitário para o estabelecimento de limites máximos de resíduos de medicamentos veterinários nos alimentos de origem animal (Texto relevante para efeitos do EEE)

formats: html pdf print

text: 15. 12. 98 PT Jornal Oficial das Comunidades Europeias L 338/5 REGULAMENTO (CE) Nº 2692/98 DA COMISS(cid:212)O de 14 de Dezembro de 1998 que altera o anexo II do Regulamento (CEE) nº 2377/90 do Conselho, que prev(cid:136) um processo comunit(cid:145)rio para o estabelecimento de limites m(cid:145)ximos de res(cid:146)duos de medicamentos veterin(cid:145)rios nos alimentos de origem animal (Texto relevante para efeitos do EEE) A COMISS(cid:212)O DAS COMUNIDADES EUROPEIAS, limites m(cid:145)ximos de res(cid:146)duos nos tecidos muscular e adiposo; Tendo em conta o Tratado que institui a Comunidade Europeia, Tendo em conta o Regulamento (CEE) nº 2377/90 do Conselho, de 26 de Junho de 1990, que prev(cid:136) um processo comunit(cid:145)rio para o estabelecimento de limites m(cid:145)ximos de res(cid:146)duos de medicamentos veterin(cid:145)rios em alimentos de origem animal (1), com a (cid:156)ltima redac(cid:135)(cid:209)o que lhe foi dada pelo Regulamento (CE) nº 2686/98 da Comiss(cid:209)o (2), e, nomeadamente, os seus artigos 6º, 7º e 8º, Considerando que, em conformidade com o Regulamento (CEE) nº 2377/90, devem ser estabelecidos progressiva- mente limites m(cid:145)ximos de res(cid:146)duos para todas as subst(cid:131)n- cias farmacologicamente activas utilizadas, na Comuni- dade, em medicamentos veterin(cid:145)rios destinados a animais produtores de alimentos para consumo humano; Considerando que os limites m(cid:145)ximos de res(cid:146)duos s(cid:155) devem ser estabelecidos ap(cid:155)s an(cid:145)lise, pelo Comit(cid:130) dos Medicamentos Veterin(cid:145)rios, de todas as informa(cid:135)(cid:210)es perti- nentes relativas (cid:133) seguran(cid:135)a dos res(cid:146)duos da subst(cid:131)ncia em quest(cid:209)o para a sa(cid:156)de do consumidor de alimentos de origem animal e (cid:133) influ(cid:136)ncia dos res(cid:146)duos na transfor- ma(cid:135)(cid:209)o dos alimentos; estabelecimento de Considerando que, no limites m(cid:145)ximos de res(cid:146)duos de medicamentos veterin(cid:145)rios em alimentos de origem animal, (cid:130) necess(cid:145)rio indicar a esp(cid:130)cie animal em que os referidos res(cid:146)duos podem estar presentes, os teores admitidos nos diferentes tecidos a analisar provenientes do animal tratado (tecido alvo), assim como a natureza do res(cid:146)duo relevante para a moni- toriza(cid:135)(cid:209)o e controlo dos res(cid:146)duos (res(cid:146)duo marcador); Considerando que, no caso de medicamentos veterin(cid:145)rios destinados a ser administrados a aves poedeiras, animais produtores de leite ou abelhas produtoras de mel, devem tamb(cid:130)m ser estabelecidos limites m(cid:145)ximos de res(cid:146)duos nos ovos, leite e mel; Considerando que sulfato de mangan(cid:136)s, ribonucleato de mangan(cid:136)s, pidolato de mangan(cid:136)s, (cid:155)xido de mangan(cid:136)s, glicerofosfato de mangan(cid:136)s, gluconato de mangan(cid:136)s, cloreto de mangan(cid:136)s e carbonato de mangan(cid:136)s devem ser inseridos no anexo II do Regulamento (CEE) nº 2377/90; Considerando que (cid:130) conveniente admitir um prazo de 60 dias, antes da entrada em vigor do presente regulamento, para que os Estados-membros possam proceder (cid:133)s neces- s(cid:145)rias altera(cid:135)(cid:210)es (cid:133)s autoriza(cid:135)(cid:210)es de introdu(cid:135)(cid:209)o no mercado dos medicamentos veterin(cid:145)rios em quest(cid:209)o, concedidas ao abrigo da Directiva 81/851/CEE do Conselho (3), com a (cid:156)ltima redac(cid:135)(cid:209)o que lhe foi dada pela Directiva 93/ /40/CEE (4), para tomarem em considera(cid:135)(cid:209)o as disposi(cid:135)(cid:210)es do presente regulamento; Considerando que as medidas previstas no presente regu- lamento est(cid:209)o de acordo com o parecer do Comit(cid:130) Perma- nente dos Medicamentos Veterin(cid:145)rios, ADOPTOU O PRESENTE REGULAMENTO: Artigo 1º O anexo II do Regulamento (CEE) nº 2377/90 (cid:130) alterado nos termos do anexo do presente regulamento. Considerando que, para o controlo de res(cid:146)duos previsto na legisla(cid:135)(cid:209)o comunit(cid:145)ria sobre a mat(cid:130)ria, devem normal- mente fixar-se limites m(cid:145)ximos de res(cid:146)duos no f(cid:146)gado e no rim; que, todavia, muitas vezes estes (cid:155)rg(cid:209)os s(cid:209)o reti- rados das carca(cid:135)as transaccionadas a n(cid:146)vel internacional e que, por conseguinte, (cid:130) conveniente estabelecer tamb(cid:130)m Artigo 2º O presente regulamento entra em vigor no sexag(cid:130)simo dia seguinte ao da sua publica(cid:135)(cid:209)o no Jornal Oficial das Comunidades Europeias. (1) JO L 224 de 18. 8. 1990, p. 1. (2) JO L 337 de 12. 12. 1998, p. 20. (3) JO L 317 de 6. 11. 1981, p. 1. (4) JO L 214 de 24. 8. 1993, p. 31. L 338/6 PT Jornal Oficial das Comunidades Europeias 15. 12. 98 O presente regulamento (cid:130) obrigat(cid:155)rio em todos os seus elementos e directamente aplic(cid:145)vel em todos os Estados-membros. Feito em Bruxelas, em 14 de Dezembro de 1998. Pela Comiss(cid:209)o Martin BANGEMANN Membro da Comiss(cid:209)o O anexo II do Regulamento (CEE) nº 2377/90 (cid:130) alterado da seguinte forma: 2. Compostos org(cid:131)nicos ANEXO Subst(cid:131)ncia(s) farmacologicamente activa(s) Esp(cid:130)cie animal Observa(cid:135)(cid:210)es «Tri(cid:155)xido de dimangan(cid:136)s Carbonato de mangan(cid:136)s Cloreto de mangan(cid:136)s Gluconato de mangan(cid:136)s Todas as esp(cid:130)cies destinadas a produ(cid:135)(cid:209)o de alimentos Apenas para utiliza(cid:135)(cid:209)o oral Todas as esp(cid:130)cies destinadas a produ(cid:135)(cid:209)o de alimentos Apenas para utiliza(cid:135)(cid:209)o oral Todas as esp(cid:130)cies destinadas a produ(cid:135)(cid:209)o de alimentos Apenas para utiliza(cid:135)(cid:209)o oral Todas as esp(cid:130)cies destinadas a produ(cid:135)(cid:209)o de alimentos Apenas para utiliza(cid:135)(cid:209)o oral Glicerofosfato de mangan(cid:136)s Todas as esp(cid:130)cies destinadas a produ(cid:135)(cid:209)o de alimentos Apenas para utiliza(cid:135)(cid:209)o oral (cid:222)xido de mangan(cid:136)s Pidolato de mangan(cid:136)s Ribonucleato de mangan(cid:136)s Sulfato de mangan(cid:136)s Todas as esp(cid:130)cies destinadas a produ(cid:135)(cid:209)o de alimentos Apenas para utiliza(cid:135)(cid:209)o oral Todas as esp(cid:130)cies destinadas a produ(cid:135)(cid:209)o de alimentos Apenas para utiliza(cid:135)(cid:209)o oral Todas as esp(cid:130)cies destinadas a produ(cid:135)(cid:209)o de alimentos Apenas para utiliza(cid:135)(cid:209)o oral Todas as esp(cid:130)cies destinadas a produ(cid:135)(cid:209)o de alimentos Apenas para utiliza(cid:135)(cid:209)o oral» 1 5. 1 2. 9 8 P T J o r n a l O f i c i a l d a s C o m u n i d a d e s E u r o p e i a s L 3 3 8 / 7


title: Proposal for a Council Decision concerning the Community position within the Association Council on the participation of Bulgaria in Community programmes in the fields of vocational training and education

eurovoc_concepts:
Association Council (EU)
Bulgaria
EU programme
education
vocational training

text: COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 14. 12. 1998 COM(1998) 750 final 98/0352 (CNS) Proposal for a COUNCIL DECISION concerning the Community position within the Association Council on the participation of Bulgaria in Community programmes in the fields of vocational training and education (presented by the Commission) Explanatory Memorandum The importance of the participation of applicant countries in Community programmes as part of the enhanced preaccession strategy which was stressed by the Commission in its "Agenda 2000" Communication of 14 July 1997, was reiterated by the European Council at its meeting of 12 and 13 December 1997 in Luxembourg. This participation will indeed help representatives from these countries to familiarise themselves with the Union's policies and working methods and with adopting the Acquis, in view of future accession. The Europe Agreements or their Additional Protocols concerning the participation in Community programmes explicitly mention the fields of vocational training and education as an eligible area. Moreover, they convey the task to define terms and conditions for participation to the Association Council. So far, the CEC's confirmed to the Commission in writing their willingness to participate in the Leonardo da Vinci and Socrates programmes. For some countries Association Council decisions were taken to this effect. Bulgaria recently also provided required information on the way it intends to finance its participation throughout the remaining life time of the Leonardo da Vinci and Socrates programmes, i. e. 1999. In view of this participation, a number of preparatory actions have been undertaken, such as the establishment of decentralised management structures in Sofia for the community programmes in the fields of vocational training (Leonardo da Vinci) and education (Socrates), which should help making this participation a success. The main issues addressed in the annexed draft Decision of the EC-Bulgaria Association Council adopting the terms and conditions for the participation of Bulgaria in the Community programme in the field of vocational training and education, are the following : • Bulgaria shall participate in all actions of the vocational training and education in conformity with the objectives, criteria and procedures of the programme (Annex I, paragraph 1). • terms and conditions for the submission, assessment and selection of applications shall be the same as for Member States (Annex I, paragraph 2). • a minimum number of partners from EC Member States shall be required for all transnational projects proposed by Bulgaria (Annex I, paragraph 3). • Bulgaria shall set up or make available national structures and mechanisms in order to implement the programme (Annex I, paragraph 4) • the financial contribution of Bulgaria is defined in Annex I, paragraph 5 and in the Annex II; bearing in mind that Bulgaria, according to article 3 of the additional protocol, shall pay the cost of its participation and that the Community may decide a financial support, the breakdown between the contribution from Bulgaria's own budget and from Phare has been indicated • best efforts shall be made to facilitate the free movement and residence of students, teachers and university administrators (Annex I, paragraph 6) • Bulgaria shall participate in the monitoring of its participation in the Programmes (Annex I, paragraph 7) • Bulgaria shall be invited to co-ordination meetings prior to meetings of the programmes Committees; it shall also be invited about its results (Annex I, paragraph 8) • the language to be used in all administrative arrangements for the programme shall be one of the official languages of the Community (Annex I, paragraph 9) • the Decision shall apply for the duration of the Programmes (Article 2 of the Decision) The adoption of Association Council decision to allow Bulgaria to participate in the Community programmes namely in Leonardo da Vinci and Socrates in 1999 will offer the country the opportunity to participate actively in this internal Community instrument, as part of the re-inforced pre-accession strategy. It is, therefore, of considerable political importance. Subject to its capacity to fulfil in time relevant administrative and budgetary requirements, Bulgaria should also be able to join other programmes in 1999. In order to allow Bulgaria to join the community programmes concerned in 1999, the Council is requested to adopt the annexed proposal for a Council decision. Proposal for a COUNCIL DECISION of concerning the Community position within the Association Council on the participation of Bulgaria in Community programmes in the fields of vocational training and education THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty establishing the European Community, and in particular Article 126 and 127, in conjunction with Article 228(3) first paragraph thereof, Having regard to the proposal from the Commission, Having regard to the opinion of the European Parliament, Whereas the Additional Protocol to the Europe Agreement establishing an association between the European Communities and their Member States, of the one part, and Bulgaria, of the other part, has been concluded by decision of the Council and the Commission of 4 December 1995. Whereas, according to Article 1 of the Additional Protocol, Bulgaria may participate in Community framework programmes, specific programmes, projects or other actions notably in the fields of vocational training and education, and pursuant to Article 2, the terms and conditions for the participation of Bulgaria in the activities referred to in Article 1 shall be decided by the Association Council, Whereas Council Decision (94/819/EC) of 6 December 1994 establishing an action programme for the implementation of a European Community vocational training policy, (hereinafter called "Leonardo da Vinci"1), and in particular Article 9,1 thereof, and Decision (819/95/EC) of 14 March 1995 of the European Parliament and of the Council establishing the Community action programme in the fields of vocational training and education (hereinafter called "Socrates")2 and in particular article 7,3 thereof, provide that these programmes shall be open to the participation of associated Central European countries in accordance with the conditions set out in the Additional Protocols to the Association Agreements on participation in Community programmes, ,O. J. n°L340of29. 12. 1994 2 O. J. no. L87 of 20. 04. 1995 HAS DECIDED AS FOLLOWS: The position to be taken by the Community within the Association Council established by the Europe Agreement between the European Communities and their Member States, of the one part, and Bulgaria, of the other part, concerning the participation of Bulgaria in Community programmes in the fields of vocational training and education, is the attached draft decision of the Association Council. Done at Brussels For the Council ANNEX Draft Decision n°. /98 of the EC-Bulgaria Association Council of adopting the terms and conditions for the participation of Bulgaria Community programmes in the fields of vocational training and education. 1999 in The ASSOCIATION COUNCIL Having regard to the Europe Agreement between the European Communities and their Member States, of the one part, and Bulgaria, of the other part,3 Having regard to the Additional Protocol to the Europe Agreement establishing an association between the European Communities and their Member States, of the one part, and Bulgaria, of the other part concerning Bulgaria's participation in Community programmes4, and in particular Article 1 and 2 thereof; Whereas according to Article 1 of the said Additional Protocol, Bulgaria may participate in Community framework programmes, specific programmes, projects or other actions notably in the fields of vocational training and education ; Whereas pursuant to Article 2 of the said Additional Protocol the terms and conditions for the participation of Bulgaria in the activities referred to in Article 1 are to be decided by the Association Council; HAS DECIDED AS FOLLOWS: Article 1 Bulgaria shall participate in the European Community programmes Leonardo da Vinci and Socrates according to the terms and conditions set out in Annexes I and II which shall form an integral part of this Decision. Article 2 This Decision shall apply for the duration of Leonardo da Vinci and Socrates programmes. Article 3 This Decision shall enter into force the first day of the month following its adoption. Done at 3 O. J. N°L 358 of 31. 12. 1994 4 O. J. N°L 317 of 30. 12. 1995 For the Association Council The Chairman Annex I Terms and conditions for the participation of Bulgaria in the Leonardo da Vinci and Socrates programmes 1. Bulgaria will participate in all activities of the Leonardo da Vinci and Socrates (hereinafter called "the Programmes") in conformity, unless otherwise provided in this Decision, with the objectives, criteria, procedures and time limits laid down in Council Decision (94/819/EC) establishing an action programme for the implementation of a European Community vocational training policy and Decision n° 819/95/EC of the European Parliament and of the Council establishing the European Community action programme Socrates. 2. - The terms and conditions for the submission, assessment and selection of applications by eligible institutions, organisations and individuals of Bulgaria shall be the same as those applicable to eligible institutions, organisations and individuals of the Community. Language preparation and vocational training activities concern the official languages of the Community. In exceptional circumstances, other languages could be accepted if the implementation of the programmes so requires. 3. To ensure the Community dimension of the Programmes, transnational projects and activities proposed by Bulgaria will be required to include a minimum number of partners from the Member States of the Community. This minimum number will be decided in the framework of the implementation of the Programmes, taking into account the nature of the various activities, the number of partners in a given project, and the number of countries participating in the Programme. Projects and activities carried out solely between Bulgaria and EFTA States which are parties to the EEA agreement or any other third countries, including those with an association agreement with the Community, to which participation in the programme is open, are not eligible for Community financial support. 4. In conformity with the terms of the relevant provisions of the Decisions on the Leonardo da Vinci and Socrates, Bulgaria will lay down the appropriate structures and mechanisms at national level and will take all other necessary steps to ensure national cor ordination and organisation of the implementation of the Programmes. 5. Bulgaria will pay each year a contribution to the general budget of the European Union to cover the costs resulting from its participation in the Programmes, (see Annex o) The Association Committee is entitled to adapt this contribution whenever necessary. 6. The Member States of the Community and Bulgaria will make every effort within the framework of the existing provisions, to facilitate the free movement and residence of students, teachers, university administrators and other eligible persons moving between Bulgaria and the Member States of the Community for the purpose of participating in activities covered by this Decision. 7 7. Without prejudice to the responsibilities of the Commission and the Court of Auditors of the European Community in relation to the monitoring and evaluation of the programmes pursuant to the Decisions concerning Leonardo da Vinci and Socrates (Articles 10 and 8 respectively), the participation of Bulgaria in the programmes will be continuously mcmitored on a partnership basis involving Bulgaria and the Commission of the European Cornmunities. Bulgaria will submit the necessary reports to the Commission and take part in other specific activities undertaken by the Community in that context. Without prejudice to the procedures referred to in Article 6 of the Decision on 8. Leonardo da Vinci and article 4 of the Decision on Socrates, Bulgaria will be invited to co-ordination meetings on any question concerning the implementation of this Decision prior to the regular meetings of the Committees. The Commission will inform Bulgaria about the results of such regular meetings. 9. The language to be used as regards the application process, contracts, reports to be submitted and other administrative arrangements for the programmes, will be one of the official languages of the Community. Annex 2 FINANCIAL CONTRIBUTION OF BULGARIA TO THE LEONARDO DA VINCI AND SOCRATES PROGRAMME •1. The financial contribution of Bulgaria will cover: subsidies or any other financial support from participants; the programmes to Bulgarian financial support from the Leonardo da Vinci programme to the functioning of the national agency; supplementary administrative costs related to the management of the programmes by the Commission stemming from Bulgaria's participation. For every financial year, the aggregated amount of subsidies or any other financial support received from the programmes by the Bulgarian beneficiaries and by the Leonardo da Vinci national agencies of Bulgaria will not exceed the contribution paid by Bulgaria, after deduction of the supplementary administrative costs. Should the contribution paid by Bulgaria to the general budget of the European Union, after deduction of the supplementary administrative costs, be higher than the aggregated amount of the subsidies or other financial support received from the programmes by the Bulgarian beneficiaries and by the Leonardo da Vinci national agency, the Commission of the European Communities will transfer the balance to the next budgetary exercise, and it will be deducted from the following year's contribu tion. Should such a balance be left when the programmes come to an end, the corre sponding amount will be reimbursed to Bulgaria. 3. Leonardo da Vinci Bulgaria's contribution for participating in 1999 will be ECU 1 114 000. From this sum, an amount of ECU 72 000 will cover supplementary administrative costs related to the management of the programme by the Commission stemming from Bulgaria's participation. 4. Socrates Bulgaria's contribution will be ECU 4 140 000 in 1999 for its participation in the entire Leonardo da Vinci and Socrates, including Chapter I (Erasmus). From this sum, an amount of ECU 270 000 will cover supplementary administrative costs related to the management of the programme by the Commission stemming from Bulgaria's participation. 5. The financial regulation applicable to the general budget of the European Union will apply, notably to the management of the contribution of Bulgaria. After the entry into force of this Decision, and at the beginning of each following year, the Commission will send to Bulgaria a call for funds corresponding to its contribution to the costs under this Decision. This contribution shall be expressed in ECU and paid into an ECU bank account of the Commission. The calculation of the annual contribution is based on a participation during a full financial year. Should the Association Council Decision enter into force in the course of a year, the contribution for that year will be adapted taking into account the state of implementation of the Programmes for that particular year. Bulgaria will pay its contribution to the annual costs under this Decision according to the call for funds, at the latest three months after the call for funds is sent. Any delay in the payment of the contribution shall give rise to the payment of interest by Bulgaria on the outstanding amount from the due date. The interest rate corresponds to the rate applied by the European Monetary Co-operation Fund, for the month of the due date, for its operations in ECU2, increased by 1,5 percentage points. 6. Bulgaria will pay the supplementary administrative costs referred to in paragraphs 3 and 4 from its national budget. 7. Of the remainder of its annual contribution to the Leonardo da Vinci programme, referred to in paragraph 3, Bulgaria will pay ECU 31 000 from its national budget in 1999. Subject to regular PHARE programming procedures, ECU 1 Oil 000 will be paid from Bulgaria's PHARE National Programme of 1999. Of the remainder of its annual contribution to the Socrates, referred to in paragraph 4, Bulgaria will pay ECU 116 000 from its national budget in 1999. Subject to regular PHARE programming procedures, ECU 3 754 000 will be paid from Bulgaria's PHARE national programme of 1999. 2 Rate published monthly in the Official Journal of the European Communities - C Series 10 FINANCIAL STATEMENT 1. TITLE OF OPERATION Participation of Bulgaria in the Leonardo da Vinci and Socrates programmes 2. BUDGET HEADING INVOLVED B7-503 - Opening of Community Programmes to the associated countries of Central and Eastern Europe 3. LEGAL BASIS Treaty establishing the European Community, and in particular Article 126 and 127, in conjunction with Article 228(3) thereof. Additional Protocol to the Europe Agreement with Bulgaria of 4 December 1995, providing for the opening-up of Community programmes (OJ No L 317/24) Council Decision (819/94/EC) of 6 December 1994 establishing the Leonardo da Vinci programme, and in particular Article 9(1) thereof, Decision of the European Parliament and of the Council (819/95/EC) of 14 March 1995 establishing the Leonardo da Vinci and Socrates, and in particular Article 7(3) thereof, ' 4. DESCRIPTION OF OPERATION: 4. 1 General objective The Additional Protocol with Bulgaria entered into force on 1 August 1996 and provides for Bulgaria's participation in Community programmes in a wide range of areas, among which vocational training and education. In line with the Commission communication "Agenda 2000" of 16. 07. 1997 and of the conclusions of the European Council in Luxembourg, Bulgaria's participation in the Leonardo da Vinci and Socrates programmes will be part of the reinforced preaccession strategy which will assist this country in its preparation for future accession to the Union. Its participation will not only contribute towards the implementation of the provisions relating to economic and cultural co-operation in the Europe Agreements but will also enable Bulgaria to familiarise itself with the procedures and methods used in Community programmes. The decision-making process for the opening-up of programmes involves a decision by the Association Council between the Union and the associated country. This decision also lays down the practical arrangements for the opening up of the programmes. /! The above-mentioned programmes are not intended to form an exhaustive list as the process for opening them up has only recently begun. Other Community programmes, notably in the fields of culture, health and social policy, energy, the environment, etc. , have been opened up to the countries of Central and Eastern Europe. 4. 2 Period covered and arrangements for renewal Until the end of the Community programmes concerned, i. e. 31. 12. 1999. 5. CLASSIFICATION OF EXPENDITURE OR REVENUE 5. 1 Non-compulsory expenditure 5. 2 Differentiated appropriations 5. 3 Type of revenue involved: Since the first paragraph of Article 3 of the Additional Protocol stipulates that Bulgaria itself will meet the costs resulting from its participation, it will be invited to transfer its contribution to item 6091 of the EU's budget receipts. However, as the second paragraph of Article 3 states that the Community may supplement Bulgaria's contribution (by up to 10% of the National Indicative Programme), Bulgaria will contribute only part from its national budget, with the remainder being charged to heading B7-503 following a transfer from heading B7-500. 6. TYPE OF EXPENDITURE OR REVENUE - 100% subsidy - subsidy for joint financing with other sources in the public and/or private sector - no provision for all or part of the Community contribution to be reimbursed As far as revenue is concerned, provision for Bulgaria's contribution to cover the cost of its participation is made under item 6091. The revenue will be allocated to the items for expenditure on the programmes in question and, where appropriate, to the relevant items of operating expenditure. The total revenue expected is given under item 7. 4. 7. FINANCIAL IMPACT 7. 1 Method of calculating total cost of operation for 1999 financial year (link between individual costs and total cost) The calculation is based on the following. preconditions: - each partner country's contribution to the financing of the activities referred to in the Protocol is calculated according to the principle that the country bears the cost of participation itself. Heading 6091 has been created in the statement of budget revenue for that purpose; 12 - the Community may decide on a case-by-case basis to pay a supplement to the partner country's contribution. The supplement may be in the form of a contribution under the PHARE programme, but the amount cannot exceed 10% of its National Indicative Programme. i Based on the Additional Protocol with Bulgaria, the financial and budgetary arrangements for the programme concerned are as follows : the f costs have been calculated on the basis of various parameters inherent in the programme, i. e. GDP, young population, distances involved. The cost of Bulgaria's participation in the Leonardo da Vinci programme will amount to ECU 1 114 000 in 1999. For Socrates, the cost will be ECU 4 140 000 in 1999. The above-mentioned figures, from which the supplementary administrative costs - to be borne exclusively by Bulgaria - have to be deducted, are divided as follows : Bulgaria will pay ECU 31 000 and ECU 116 000 of the operational costs of its participation in the Leonardo et Leonardo da Vinci and Socrates respectively from its national budget of 1999 ; subject to regular PHARE programming procedures, the remaining ECU 1 011 000 and ECU 3 754 000 will be paid from Bulgaria's annual PHARE National Indicative Programme of 1999. 7. 2 Itemised breakdown of cost in ECU Programme 1999 of which Bulgaria of which Phare Leonardo da Vinci 1 042 000 31 000 1011000 Socrates Total 3 870 000 116 000 3 754 000 4 912 000 147 000 4 765 000 in ecu 7. 3 Operational expenditure on studies, expert meetings, etc. , included in Part B: None /a-14 7. 4 Schedule for multiannual operations Amounts to be charged to item B7-503 1999 TOTAL 4 765 000 I 4 765 000 Commitment appropriations payment appropriations 1999 subsequent years Total 4 180 000 585 000 4 765 000 [ 4 765 000 •(*) Schedule based on the method of payment currently applying to the Leonardo da Vinci and Socrates programmes. The foreseeable annual receipts are as follows: Item 6091 1999 I subsequent I TOTAL years operational part administrative part Total 147 000 342 000 489 000 | 147 000 342 000 489 000 | 8. FRAUD PREVENTION MEASURES; RESULTS OF MEASURES TAKEN All the Commission's contracts, agreements and other legal commitments provide for on- the-spot checks by the Commission and Court of Auditors. Among other things, the beneficiaries of the operations are obliged to file reports and financial statements. These are analysed from the point of view of their content and the eligibility of the expenditure in line with the objective of Community financing. The anti-fraud provisions of the basic budget headings apply to this heading too when adapted to the case of the countries of Central and Eastern Europe. 9. ELEMENTS OF COST-EFFECTIVENESS ANALYSIS 9. 1. Specific and quantified objectives; target population The aim of opening up the Leonardo da Vinci and Socrates programmes to Bulgaria is to bring it the same benefits as the Member States of the Community already enjoy from these programmes. The essential aim of Community action on education and vocational training should be to enable all European citizens to achieve their full potential and display initiative and creativity so that they can participate fully in society and in the building of Europe. This objective is based on the gradual establishment of an open European area for education and vocational training. 15 In the fields of vocational training and education, the principal aim of the Leonardo da Vinci and Socrates is to contribute to the development of quality education by encouraging co-operation between Member States. The specific aims of the Socrates programme are: • to develop the European dimension in education at all levels so as to strengthen the spirit of European citizenship, drawing on the cultural heritage of each Member State; • to promote a quantitative and qualitative improvement of the knowledge of the languages of the European Union, and in particular those which are least widely used and least taught, leading to greater understanding and solidarity between the peoples of the European Union, and to promote the intercultural dimension of education; • to promote wide-ranging and intensive co-operation between institutions at all levels of education, enhancing their intellectual and teaching potential; • to encourage the mobility of teachers, so as to promote a European dimension in studies and to contribute to the qualitative improvement of their skills; • to encourage mobility for students, enabling them to complete part of their studies in another Member State, so as to contribute to the consolidation of the European dimension in education; • to encourage contacts among pupils in the European Union, and to promote the European dimension in their education; • to encourage the academic recognition of diplomas, periods of study and other qualifications, with the aim of facilitating the development of an open European area for education; • to encourage open and distance education in the context of the activities of this programme; • to foster exchanges of information and experience so that the diversity and specificity of the educational systems in the Member States become a source of enrichment and of mutual stimulation. In the field of vocational training, the principal aim of the Leonardo da Vinci programme is to implement a vocational training policy which supports and supplements the action of the Member States. The main objectives of the programme are to: • support the improvement of the vocational-training systems and arrangements in the Member States by: improving the quality of initial vocational training and the transition of young people to working life, improving the quality of the Member States' continuing vocational training arrangements, supporting vocational information and guidance, promoting equal opportunities for men and women in vocational, training, improving the quality of vocational training arrangements for persons disadvantaged on the labour market, for example owing to socio-economic, geographical or ethnic factors or by physical or mental disabilities or a lack of qualifications or insufficient qualifications such that they are at risk of social exclusion; • support for the improvement of vocational including university/industry co-operation, concerning undertakings and workers: innovation in vocational training, with a view to taking into account technological change and its impact on work and the necessary qualifications and skills, investment in continuing vocational training for workers, the transfer of technological innovation training measures 16 in the context of co-operation between undertakings and universities in the field of continuing vocational training, the promotion of equal opportunities for men and women; • support for the development of language skills, knowledge and the dissemination of innovation in the field of vocational training. 9. 2. Grounds for the operation - Need for Community financial aid In view of the high cost of participation in the programmes and Bulgaria's precarious budgetary situation, assistance from PHARE as provided for in Article 3(2) of the Additional Protocol is essential. - Choice of ways and means With a contribution from PHARE, supplemented by one from the national budget, Bulgaria's integration in the programmes concerned will put it on an equal footing with the current EU Member States. The integration of Bulgarian nationals in Community networks will make a definite contribution to preparing Bulgaria for future membership. - Main factors of uncertainty which could affect the specific results of the operation Since projects will be selected according to qualitative criteria, it will only be possible to measure the real impact on the basis of Bulgarian firms' capacity to respond to the calls for proposal to be launched by the Commission under the programmes. 9. 3 Monitoring and evaluation of the operation The monitoring and evaluation procedures included in the Leonardo da Vinci and Socrates programmes (notably in respect of evaluation, as included in the decisions establishing the programmes) will also cover operations financed for Bulgarian beneficiaries. 10. ADMINISTRATIVE EXPENDITURE The administrative resources required will actually be mobilised following the annual Commission Decision on the allocation of resources, taking account in particular of manpower and additional amounts granted by the budgetary authority. the request of new posts in the framework of APB, a) b) the resources allocation. 17 10. 1 Impact on the number of posts Type of post Staff required to manage the operation Permanent posts Temporary posts including Using existing resources of the departments concerned duration 1999 using additional resources or Officials temporary staff A B C Other resources (A-7002) TOTAL 1 1 2 1 1 2 2,98 2,98 2,98 2,98 18 10. 2 Overall financial impact of the additional human resources Temporary staff Other resources (A-7002) Total Method of calculation (in ecu) 298 000 2,98 man x 100. 000 ECU x 1 year = 298 000 ECU TOTAL 1 298 000 | (*) Calculations based on titles Al, A2, A4, A5 and A7. For item A-7002 the additional expenditure will be met from the receipts (article 4 par. 2, third indent of the financial regulation) received from Bulgaria's participation in Community programmes (see point 5. 3 of the financial statement) The expenses concerning the human resources needed to carry out this task that will be met through the allocation of the existing resources (calculations based on titles Al, A2, A4, A5 and A7) are estimated to 216 000 ECU (1 A post and 1 B post in 1999) 10. 3 Increase in other operating expenses as a result of the operation Budget heading (No and title) Total A7010-missions 7 000 A7030 - meetings 37 000 (in ecu) Method of calculation (total cost of the operation in 1999) 1 166 ECU x 3 missions x 2 programmes = 6. 996 ECU (roundup to 7. 000 ECU) 2 Bulgarian representatives x 1. 166 ECU x 8 meetings x 2 programmes = 37 312 ECU (round down to 37 000 ECU) Total 1 44. 000 1 The above expenditure will be met from the receipts (article 4 par. 2, third indent of the financial regulation) received from Bulgaria's participation in Community programmes (see point 5. 3 of the financial statement). 19 ISSN 0254-1475 COM(98) 750 final DOCUMENTS EN 16 04 11 15 Catalogue number : CB-CO-98-747-EN-C Office for Official Publications of the European Communities L-2985 Luxembourg 2


title: Smernica Rady 98/92/ES zo 14. decembra 1998, ktorou sa mení a dopĺňa smernica 70/524/EHS o prídavných látkach v krmivách a smernica 95/69/ES, ktorou sa stanovujú podmienky a opatrenia na schválenie a evidenciu určitých podnikov a sprostredkovateľov pôsobiacich v sektore krmív

eurovoc_concepts:
animal nutrition
food additive
food industry
health control
product quality
quasi-fiscal charge

text: 03/zv. 24 SK Úradný vestník Európskej únie 209 31998L0092 22. 12. 1998 ÚRADNÝ VESTNÍK EURÓPSKYCH SPOLOČENSTIEV L 346/49 SMERNICA RADY 98/92/ES zo 14. decembra 1998, ktorou sa mení a dopĺňa smernica 70/524/EHS o prídavných látkach v krmivách a smernica 95/69/ES, ktorou sa stanovujú podmienky a opatrenia na schválenie a evidenciu určitých podnikov a sprostredkovateľov pôsobiacich v sektore krmív RADA EURÓPSKEJ ÚNIE, Článok 6 (2) sa nahrádza nasledujúcim textom: so zreteľom na Zmluvu o založení Európskeho spoločenstva, najmä na jej článok 43, so zreteľom na návrh Komisie (1), so zreteľom na stanovisko Európskeho parlamentu (2), so zreteľom na výboru (3), stanovisko Hospodárskeho a sociálneho keďže článok 14 smernice Rady 95/69/ES (4) stanovuje, že Rada prijme výšku poplatkov, ktoré sa budú účtovať za schválenie podnikov a ich sprostredkovateľov; keďže článok 6 smernice Rady 70/524/EHS z 23. novembra 1970 o prídavných látkach v krmivách (5) že poplatky môže účtovať členský štát, ktorý koná ako spravo- dajca pri preskúmaní dokumentácie týkajúcej sa schvaľovania spoločenstva prídavných látok do krmív; keďže Rada stanoví výšku takéhoto poplatku; stanovuje, keďže prešetrenie financovania daných služieb v jednotlivých členských štátoch preukázalo, že stanovenie výšky poplatkov na úrovni spoločenstva by bolo neprimeraným zasahovaním do doterajších odvodových systémov poplatkov spravovaných členskými štátmi; keďže popritom sa tiež veľmi líšia náklady, ktoré členským štátom vznikajú pri poskytovaní takýchto služieb, hlavne z dôvodu veľkých rozdielov v pracovných nákladoch; keďže, aby sa predišlo narušeniu hospodárskej súťaže, malo by sa zriadiť ustanovenie o tom, že Rada musí rozhodnúť o har- monizácií pravidiel výpočtu výšky poplatkov; keďže by sa príslušné ustanovenia a 95/69/ES mali náležite zmeniť a doplniť, smerníc 70/524/EHS PRIJALA TÚTO SMERNICU: Článok 1 Smernica 70/524/EHS sa týmto mení a dopĺňa takto: (1) Ú. v. ES C 155, 20. 5. 1998, s. 29. (2) Ú. v. ES C 292, 21. 9. 1998. (3) Ú. v. ES C 284, 14. 9. 1998, s. 91. (4) Ú. v. ES L 332, 30. 12. 1995, s. 15. (5) Ú. v. ES L 270, 14. 12. 1970, s. 1. Smernica naposledy zmenená a doplnená smernicou 98/19/ES (Ú. v. ES L 96, 28. 3. 1998, s. 39). „2. Pred 1. aprílom 1999 Rada konajúca na základe kvalifikovanej väčšiny, na návrh Komisie prijme pravidlá výpočtu výšky poplatku, na ktorý sa vzťahuje odsek 1. “ Článok 2 Smernica 95/69/ES sa týmto mení a dopĺňa takto: Článok 14 sa nahrádza takto: „Článok 14 Pred 1. aprílom 1999 Rada konajúca na základe kvalifiko- vanej väčšiny, na návrh Komisie prijme pravidlá výpočtu výšky poplatku, ktorý sa bude účtovať za schválenie podnikov a ich sprostredkovateľov. “ Článok 3 1. iné Členské štáty prijmú do 31. marca 1999 zákony, právne predpisy a správne opatrenia potrebné na vytvorenie súladu s touto smernicou. Bezodkladne o tom informujú Komisiu. Keď členské štáty prijmú tieto opatrenia, uvedú v nich odkaz na túto smernicu alebo ich takýto odkaz bude sprevádzať pri príležitosti ich úradného uverejnenia. Spôsob vykonania tohto odkazu ustanovia členské štáty. 2. Členské štáty oznámia Komisii text hlavných ustanovení vnútroštátnych zákonov, ktoré prijmú v oblasti spravovanej touto smernicou. Článok 4 Toto nariadenie nadobudne účinnosť dňom jeho uverejnenia v Úradnom vestníku Európskych spoločenstiev. 210 SK Úradný vestník Európskej únie 03/zv. 24 Táto smernica je adresovaná členským štátom. Článok 5 V Bruseli 14. decembra 1998 Za Radu predseda W. MOLTERER


title: ΚΟΙΝΗ ΘΕΣΗ (ΕΚ) αριθ. 2/1999 που καθορίστηκε από το Συμβούλιο στις 14 Δεκεμβρίου 1998 για την έκδοση της οδηγίας 1999/.../ΕΚ του Ευρωπαϊκού Κοινοβουλίου και του Συμβουλίου, της ..., σχετικά με τη δέκατη έβδομη τροποποίηση της οδηγίας 76/769/ΕΟΚ του Συμβουλίου περί προσεγγίσεως των νομοθετικών, κανονιστικών και διοικητικών διατάξεων των κρατών μελών που αφορούν περιορισμούς της κυκλοφορίας στην αγορά και της χρήσης μερικών επικίνδυνων ουσιών και παρασκευασμάτων

eurovoc_concepts:
approximation of laws
consumer protection
dangerous substance
marketing restriction
public health

text: 22. 1. 1999 EL Ε(cid:240)(cid:221)(cid:243)ηµη Ε(cid:230)ηµ(cid:229)ρ(cid:221)(cid:228)Æ (cid:244)ων Ευρω(cid:240)Æϊκω(cid:139) ν Κ(cid:239)Øν(cid:239)(cid:244)η(cid:139) (cid:244)ων C 18/43 ΚˆΙΝΗ ΘΕΣΗ (ΕΚ) ÆρØθ. 2/1999 (cid:240)(cid:239)υ κÆθ(cid:239)ρ(cid:221)(cid:243)(cid:244)ηκ(cid:229) Æ(cid:240)(cid:222) (cid:244)(cid:239) Συµ(cid:226)(cid:239)υ(cid:139) λØ(cid:239) (cid:243)(cid:244)Øς 14 ∆(cid:229)κ(cid:229)µ(cid:226)ρ(cid:221)(cid:239)υ 1998 γØÆ (cid:244)ην (cid:229)(cid:139)κ(cid:228)(cid:239)(cid:243)η (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 1999/. /ΕΚ (cid:244)(cid:239)υ Ευρω(cid:240)Æϊκ(cid:239)υ(cid:139) Κ(cid:239)Øν(cid:239)(cid:226)(cid:239)υλ(cid:221)(cid:239)υ κÆØ (cid:244)(cid:239)υ Συµ(cid:226)(cid:239)υλ(cid:221)(cid:239)υ, (cid:244)ης. , (cid:243)ł(cid:229)(cid:244)Øκ(cid:192) µ(cid:229) (cid:244)η (cid:228)(cid:229)(cid:139) κÆ(cid:244)η (cid:229)(cid:139) (cid:226)(cid:228)(cid:239)µη (cid:244)ρ(cid:239)(cid:240)(cid:239)(cid:240)(cid:239)(cid:221)η(cid:243)η (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 76/769/ΕˆΚ (cid:244)(cid:239)υ Συµ(cid:226)(cid:239)υλ(cid:221)(cid:239)υ (cid:240)(cid:229)ρ(cid:221) (cid:240)ρ(cid:239)(cid:243)(cid:229)γγ(cid:221)(cid:243)(cid:229)ως (cid:244)ων ν(cid:239)µ(cid:239)θ(cid:229)(cid:244)Øκω(cid:139) ν, κÆν(cid:239)νØ(cid:243)(cid:244)Øκω(cid:139) ν κÆØ (cid:228)Ø(cid:239)Øκη(cid:244)Øκω(cid:139) ν (cid:228)ØÆ(cid:244)(cid:192)Œ(cid:229)ων (cid:244)ων κρÆ(cid:244)ω(cid:139) ν µ(cid:229)λω(cid:139) ν (cid:240)(cid:239)υ Æ(cid:230)(cid:239)ρ(cid:239)υ(cid:139) ν (cid:240)(cid:229)ρØ(cid:239)ρØ(cid:243)µ(cid:239)υ(cid:139) ς (cid:244)ης κυκλ(cid:239)(cid:230)(cid:239)ρ(cid:221)Æς (cid:243)(cid:244)ην Æγ(cid:239)ρ(cid:192) κÆØ (cid:244)ης łρη(cid:139) (cid:243)ης µ(cid:229)ρØκω(cid:139) ν (cid:229)(cid:240)Øκ(cid:221)ν(cid:228)υνων (cid:239)υ(cid:243)Øω(cid:139) ν κÆØ (cid:240)ÆρÆ(cid:243)κ(cid:229)υÆ(cid:243)µ(cid:192)(cid:244)ων (1999/C 18/02) Τˆ ΕΥΡΩΠΑÏΚˆ ΚˆΙΝˆΒˆΥΛΙˆ ΚΑΙ Τˆ ΣΥΜΒˆΥΛΙˆ ΤΗΣ ΕΥΡΩΠΑÏΚΗΣ ΕΝΩΣΗΣ, ˛ł(cid:239)ν(cid:244)Æς υ(cid:240)(cid:222)ψη: (cid:244)η (cid:243)υνθη(cid:139) κη γØÆ (cid:244)ην (cid:221)(cid:228)ρυ(cid:243)η (cid:244)ης Ευρω(cid:240)Æϊκη(cid:139) ς Κ(cid:239)Øν(cid:222)(cid:244)η(cid:244)Æς, κÆØ Ø(cid:228)(cid:221)ως (cid:244)(cid:239) (cid:192)ρθρ(cid:239) 100 Α, (cid:244)ην (cid:240)ρ(cid:222)(cid:244)Æ(cid:243)η (cid:244)ης Ε(cid:240)Ø(cid:244)ρ(cid:239)(cid:240)η(cid:139) ς (1), (cid:244)η γνω(cid:139) µη (cid:244)ης ˆØκ(cid:239)ν(cid:239)µØκη(cid:139) ς κÆØ Κ(cid:239)ØνωνØκη(cid:139) ς Ε(cid:240)Ø(cid:244)ρ(cid:239)(cid:240)η(cid:139) ς (2), Α(cid:240)(cid:239)(cid:230)Æ(cid:243)(cid:221)œ(cid:239)ν(cid:244)Æς (cid:243)υ(cid:139) µ(cid:230)ωνÆ µ(cid:229) (cid:244)η (cid:228)ØÆ(cid:228)ØκÆ(cid:243)(cid:221)Æ (cid:244)(cid:239)υ (cid:192)ρθρ(cid:239)υ 189 Β (cid:244)ης (cid:243)υνθη(cid:139) κης (3), Εκ(cid:244)Øµω(cid:139) ν(cid:244)Æς: (1) (2) (3) (4) (cid:222)(cid:244)Ø θÆ (cid:240)ρ(cid:229)(cid:139) (cid:240)(cid:229)Ø νÆ θ(cid:229)(cid:243)(cid:240)Ø(cid:243)θ(cid:239)υ(cid:139) ν (cid:244)Æ ÆνÆγκÆ(cid:221)Æ µ(cid:229)(cid:139) (cid:244)ρÆ γØÆ (cid:244)ην κÆλη(cid:139) λ(cid:229)Ø(cid:244)(cid:239)υργ(cid:221)Æ (cid:244)ης (cid:229)(cid:243)ω(cid:244)(cid:229)ρØκη(cid:139) ς Æγ(cid:239)ρ(cid:192)ςﬂ (cid:222)(cid:244)Ø (cid:244)(cid:239) Ευρω(cid:240)Æϊκ(cid:222) Κ(cid:239)Øν(cid:239)(cid:226)(cid:239)υ(cid:139) λØ(cid:239) κÆØ (cid:244)(cid:239) Συµ(cid:226)(cid:239)υ(cid:139) λØ(cid:239) (cid:229)Œ(cid:229)(cid:139) (cid:228)ω(cid:243)Æν, (cid:243)(cid:244)Øς 29 ΜÆρ(cid:244)(cid:221)(cid:239)υ 1996, (cid:244)ην Æ(cid:240)(cid:222)(cid:230)Æ(cid:243)η ÆρØθ. 646/96/ΕΚ (4) γØÆ (cid:244)η θ(cid:229)(cid:139) (cid:243)(cid:240)Ø(cid:243)η (cid:243)ł(cid:229)(cid:228)(cid:221)(cid:239)υ (cid:228)ρ(cid:192)(cid:243)ης γØÆ (cid:244)ην κÆ(cid:244)Æ(cid:240)(cid:239)λ(cid:229)(cid:139) µη(cid:243)η (cid:244)(cid:239)υ κÆρκ(cid:221)ν(cid:239)υ (cid:229)ν(cid:244)(cid:222)ς (cid:244)(cid:239)υ (cid:240)λÆ(cid:221)(cid:243)Ø(cid:239)υ (cid:228)ρ(cid:192)(cid:243)ης (cid:243)(cid:244)(cid:239)ν (cid:244)(cid:239)µ(cid:229)(cid:139) Æ (cid:244)ης (cid:228)ηµ(cid:222)(cid:243)ØÆς υγ(cid:229)(cid:221)Æς (1996- 2000)ﬂ (cid:222)(cid:244)Ø, γØÆ νÆ (cid:229)νØ(cid:243)łυθ(cid:229)(cid:221) η (cid:240)ρ(cid:239)(cid:243)(cid:244)Æ(cid:243)(cid:221)Æ (cid:244)ης υγ(cid:229)(cid:221)Æς κÆØ η Æ(cid:243)(cid:230)(cid:192)λ(cid:229)ØÆ (cid:244)ων κÆ(cid:244)ÆνÆλω(cid:244)ω(cid:139) ν, (cid:239)υ(cid:243)(cid:221)(cid:229)ς (cid:244)ÆŒØν(cid:239)µηµ(cid:229)(cid:139) ν(cid:229)ς ως κÆρκØν(cid:239)γ(cid:222)ν(cid:229)ς, µ(cid:229)(cid:244)ÆλλÆŒØγ(cid:222)ν(cid:229)ς η(cid:139) (cid:244)(cid:239)ŒØκ(cid:229)(cid:139) ς γØÆ (cid:244)ην ÆνÆ(cid:240)ÆρÆγωγη(cid:139) , κÆθω(cid:139) ς κÆØ (cid:244)Æ (cid:240)ÆρÆ(cid:243)κ(cid:229)υ(cid:192)(cid:243)µÆ(cid:244)Æ (cid:240)(cid:239)υ (cid:244)Øς (cid:240)(cid:229)ρØ(cid:229)(cid:139) ł(cid:239)υν, (cid:228)(cid:229)ν θÆ (cid:240)ρ(cid:229)(cid:139) (cid:240)(cid:229)Ø νÆ κυκλ(cid:239)(cid:230)(cid:239)ρ(cid:239)υ(cid:139) ν (cid:243)(cid:244)ην Æγ(cid:239)ρ(cid:192) (cid:240)ρ(cid:239)ς (cid:228)Ø(cid:192)θ(cid:229)(cid:243)η (cid:243)(cid:244)(cid:239) (cid:229)υρυ(cid:139) κ(cid:239)Øν(cid:222)ﬂ (cid:222)(cid:244)Ø, µ(cid:229) (cid:244)ην (cid:239)(cid:228)ηγ(cid:221)Æ 94/60/ΕΚ (cid:244)(cid:239)υ Ευρω(cid:240)Æϊκ(cid:239)υ(cid:139) Κ(cid:239)Øν(cid:239)- (cid:226)(cid:239)υλ(cid:221)(cid:239)υ κÆØ (cid:244)(cid:239)υ Συµ(cid:226)(cid:239)υλ(cid:221)(cid:239)υ, (cid:244)ης 20η(cid:139) ς ∆(cid:229)κ(cid:229)µ(cid:226)ρ(cid:221)(cid:239)υ 1994, γØÆ (cid:244)η (cid:228)(cid:229)(cid:139) κÆ(cid:244)η (cid:244)(cid:229)(cid:139) (cid:244)Æρ(cid:244)η (cid:244)ρ(cid:239)(cid:240)(cid:239)(cid:240)(cid:239)(cid:221)η(cid:243)η (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)- Æς 76/769/ΕˆΚ (cid:240)(cid:229)ρ(cid:221) (cid:240)ρ(cid:239)(cid:243)(cid:229)γγ(cid:221)(cid:243)(cid:229)ως (cid:244)ων ν(cid:239)µ(cid:239)θ(cid:229)(cid:244)Øκω(cid:139) ν, κÆν(cid:239)νØ(cid:243)(cid:244)Øκω(cid:139) ν κÆØ (cid:228)Ø(cid:239)Øκη(cid:244)Øκω(cid:139) ν (cid:228)ØÆ(cid:244)(cid:192)Œ(cid:229)ων (cid:244)ων κρÆ- (1) ΕΕ C 59 (cid:244)ης 25. 2. 1998, (cid:243). 5. (2) ΕΕ C 214 (cid:244)ης 10. 7. 1998, (cid:243). 73. (3) Γνω(cid:139) µη (cid:244)(cid:239)υ Ευρω(cid:240)Æϊκ(cid:239)υ(cid:139) Κ(cid:239)Øν(cid:239)(cid:226)(cid:239)υλ(cid:221)(cid:239)υ (cid:244)ης 18ης Φ(cid:229)(cid:226)ρ(cid:239)υÆρ(cid:221)(cid:239)υ 1998 (ΕΕ C 80 (cid:244)ης 16. 3. 1998, (cid:243). 91), κ(cid:239)Øνη(cid:139) θ(cid:229)(cid:139) (cid:243)η (cid:244)(cid:239)υ Συµ(cid:226)(cid:239)υ- λ(cid:221)(cid:239)υ (cid:244)ης 14ης ∆(cid:229)κ(cid:229)µ(cid:226)ρ(cid:221)(cid:239)υ 1998 κÆØ Æ(cid:240)(cid:222)(cid:230)Æ(cid:243)η (cid:244)(cid:239)υ Ευρω(cid:240)Æϊκ(cid:239)υ(cid:139) Κ(cid:239)Øν(cid:239)(cid:226)(cid:239)υλ(cid:221)(cid:239)υ (cid:244)ης. ((cid:228)(cid:229)ν (cid:229)(cid:139) ł(cid:229)Ø Æκ(cid:222)µÆ (cid:228)ηµ(cid:239)(cid:243)Ø(cid:229)υθ(cid:229)(cid:221) (cid:243)(cid:244)ην Ε(cid:240)(cid:221)(cid:243)η- µη Ε(cid:230)ηµ(cid:229)ρ(cid:221)(cid:228)Æ). (4) ΕΕ L 95 (cid:244)ης 16. 4. 1996, (cid:243). 9. (cid:244)ω(cid:139) ν µ(cid:229)λω(cid:139) ν (cid:240)(cid:239)υ Æ(cid:230)(cid:239)ρ(cid:239)υ(cid:139) ν (cid:240)(cid:229)ρØ(cid:239)ρØ(cid:243)µ(cid:239)υ(cid:139) ς κυκλ(cid:239)(cid:230)(cid:239)ρ(cid:221)Æς (cid:243)(cid:244)ην Æγ(cid:239)ρ(cid:192) κÆØ łρη(cid:139) (cid:243)(cid:229)ως µ(cid:229)ρØκω(cid:139) ν (cid:229)(cid:240)Øκ(cid:221)ν(cid:228)υνων (cid:239)υ(cid:243)Øω(cid:139) ν κÆØ (cid:240)ÆρÆ(cid:243)κ(cid:229)υÆ(cid:243)µ(cid:192)(cid:244)ων (5), κÆ(cid:244)Æρ(cid:244)(cid:221)œ(cid:229)(cid:244)ÆØ, υ(cid:240)(cid:222) µ(cid:239)ρ(cid:230)η(cid:139) (cid:240)ρ(cid:239)(cid:243)Æρ(cid:244)η(cid:139) µÆ(cid:244)(cid:239)ς, (cid:243)(cid:244)Æ (cid:243)ηµ(cid:229)(cid:221)Æ 29, 30 κÆØ 31 (cid:244)(cid:239)υ (cid:240)ÆρÆρ(cid:244)η(cid:139) µÆ(cid:244)(cid:239)ς I (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 76/769/ΕˆΚ (6), κÆ(cid:244)(cid:192)- λ(cid:239)γ(cid:239)ς (cid:240)(cid:239)υ Æ(cid:240)ÆρØθµ(cid:229)(cid:221) (cid:244)Øς (cid:239)υ(cid:243)(cid:221)(cid:229)ς (cid:239)Ø (cid:239)(cid:240)(cid:239)(cid:221)(cid:229)ς (cid:244)ÆŒØν(cid:239)µ(cid:239)υ(cid:139) - ν(cid:244)ÆØ ως κÆρκØν(cid:239)γ(cid:222)ν(cid:229)ς, µ(cid:229)(cid:244)ÆλλÆŒØγ(cid:222)ν(cid:229)ς η(cid:139) (cid:244)(cid:239)ŒØκ(cid:229)(cid:139) ς γØÆ (cid:244)ην ÆνÆ(cid:240)ÆρÆγωγη(cid:139) , κÆ(cid:244)ηγ(cid:239)ρ(cid:221)Æς 1 η(cid:139) 2ﬂ (cid:222)(cid:244)Ø Æυ(cid:244)(cid:229)(cid:139) ς (cid:239)Ø (cid:239)υ(cid:243)(cid:221)(cid:229)ς κÆØ (cid:244)Æ (cid:240)ÆρÆ(cid:243)κ(cid:229)υ(cid:192)(cid:243)µÆ(cid:244)Æ (cid:240)(cid:239)υ (cid:244)Øς (cid:240)(cid:229)ρØ(cid:229)(cid:139) ł(cid:239)υν (cid:228)(cid:229)ν µ(cid:240)(cid:239)ρ(cid:239)υ(cid:139) ν νÆ κυκλ(cid:239)(cid:230)(cid:239)ρ(cid:239)υ(cid:139) ν (cid:243)(cid:244)ην Æγ(cid:239)ρ(cid:192) (cid:240)ρ(cid:239)ς (cid:228)Ø(cid:192)θ(cid:229)(cid:243)η (cid:243)(cid:244)(cid:239) (cid:229)υρυ(cid:139) κ(cid:239)Øν(cid:222)ﬂ (cid:222)(cid:244)Ø η (cid:239)(cid:228)ηγ(cid:221)Æ 94/60/ΕΚ (cid:240)ρ(cid:239)(cid:226)λ(cid:229)(cid:139) (cid:240)(cid:229)Ø (cid:222)(cid:244)Ø η Ε(cid:240)Ø(cid:244)ρ(cid:239)(cid:240)η(cid:139) υ(cid:240)(cid:239)(cid:226)(cid:192)λ(cid:229)Ø (cid:243)(cid:244)(cid:239) Ευρω(cid:240)Æϊκ(cid:222) Κ(cid:239)Øν(cid:239)(cid:226)(cid:239)υ(cid:139) λØ(cid:239) κÆØ (cid:243)(cid:244)(cid:239) Συµ(cid:226)(cid:239)υ(cid:139) λØ(cid:239) (cid:240)ρ(cid:222)(cid:244)Æ(cid:243)η γØÆ (cid:244)η (cid:243)υµ(cid:240)λη(cid:139) ρω(cid:243)η (cid:244)(cid:239)υ κÆ(cid:244)Æ- λ(cid:222)γ(cid:239)υ Æυ(cid:244)(cid:239)υ(cid:139) , (cid:229)ν(cid:244)(cid:222)ς (cid:229)(cid:139) ŒØ µηνω(cid:139) ν (cid:244)(cid:239) Æργ(cid:222)(cid:244)(cid:229)ρ(cid:239) Æ(cid:240)(cid:222) (cid:244)η (cid:228)ηµ(cid:239)(cid:243)(cid:221)(cid:229)υ(cid:243)η (cid:240)ρ(cid:239)(cid:243)Æρµ(cid:239)γη(cid:139) ς (cid:243)(cid:244)ην (cid:244)(cid:229)łνØκη(cid:139) (cid:240)ρ(cid:222)(cid:239)(cid:228)(cid:239) (cid:244)(cid:239)υ (cid:240)ÆρÆρ(cid:244)η(cid:139) µÆ(cid:244)(cid:239)ς I (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 67/548/ΕˆΚ (7), (cid:244)(cid:239) (cid:239)(cid:240)(cid:239)(cid:221)(cid:239) Æ(cid:240)ÆρØθµ(cid:229)(cid:221) (cid:244)Øς (cid:239)υ(cid:243)(cid:221)(cid:229)ς (cid:239)Ø (cid:239)(cid:240)(cid:239)(cid:221)(cid:229)ς (cid:244)ÆŒØν(cid:239)µ(cid:239)υ(cid:139) ν(cid:244)ÆØ ως κÆρκØν(cid:239)γ(cid:222)ν(cid:229)ς, µ(cid:229)(cid:244)ÆλλÆŒØγ(cid:222)ν(cid:229)ς η(cid:139) (cid:244)(cid:239)ŒØκ(cid:229)(cid:139) ς γØÆ (cid:244)ην ÆνÆ(cid:240)ÆρÆγωγη(cid:139) , κÆ(cid:244)ηγ(cid:239)ρ(cid:221)Æς 1 η(cid:139) 2ﬂ (cid:222)(cid:244)Ø η (cid:239)(cid:228)ηγ(cid:221)Æ 96/54/ΕΚ (cid:244)ης Ε(cid:240)Ø(cid:244)ρ(cid:239)(cid:240)η(cid:139) ς (8), γØÆ (cid:244)ην (cid:240)ρ(cid:239)(cid:243)Æρµ(cid:239)γη(cid:139) (cid:243)(cid:244)ην (cid:244)(cid:229)łνØκη(cid:139) (cid:240)ρ(cid:222)(cid:239)(cid:228)(cid:239), γØÆ (cid:229)Øκ(cid:239)(cid:243)(cid:244)η(cid:139) (cid:228)(cid:229)υ(cid:139) - (cid:244)(cid:229)ρη (cid:230)(cid:239)ρ(cid:192), (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 67/548/ΕˆΚ, κÆØ Ø(cid:228)(cid:221)ως (cid:244)(cid:239)υ (cid:240)ÆρÆρ(cid:244)η(cid:139) µÆ(cid:244)(cid:239)ς I, (cid:240)(cid:229)ρØλÆµ(cid:226)(cid:192)ν(cid:229)Ø 16 (cid:239)υ(cid:243)(cid:221)(cid:229)ς (cid:240)(cid:239)υ (cid:240)ρ(cid:222)- (cid:243)(cid:230)Æ(cid:244)Æ (cid:244)ÆŒØν(cid:239)µη(cid:139) θηκÆν ως κÆρκØν(cid:239)γ(cid:222)ν(cid:229)ς, µ(cid:229)(cid:244)ÆλλÆŒØ- γ(cid:222)ν(cid:229)ς η(cid:139) (cid:244)(cid:239)ŒØκ(cid:229)(cid:139) ς γØÆ (cid:244)ην ÆνÆ(cid:240)ÆρÆγωγη(cid:139) κÆ(cid:244)ηγ(cid:239)ρ(cid:221)Æς 1 η(cid:139) 2ﬂ (cid:222)(cid:244)Ø (cid:239)Ø (cid:239)υ(cid:243)(cid:221)(cid:229)ς Æυ(cid:244)(cid:229)(cid:139) ς θÆ (cid:240)ρ(cid:229)(cid:139) (cid:240)(cid:229)Ø νÆ (cid:240)ρ(cid:239)(cid:243)(cid:244)(cid:229)θ(cid:239)υ(cid:139) ν (cid:243)(cid:244)(cid:239) (cid:240)ρ(cid:239)(cid:243)(cid:192)ρ(cid:244)ηµÆ, (cid:243)(cid:244)Æ (cid:243)ηµ(cid:229)(cid:221)Æ 29, 30 κÆØ 31 (cid:244)(cid:239)υ (cid:240)ÆρÆρ(cid:244)η(cid:139) µÆ(cid:244)(cid:239)ς I (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 76/769/ΕˆΚ, (cid:222)(cid:240)ως (cid:244)(cid:239) (cid:240)ρ(cid:239)(cid:243)(cid:192)ρ(cid:244)ηµÆ Æυ(cid:244)(cid:222) (cid:229)(cid:139) ł(cid:229)Ø (cid:229)ν(cid:239)(cid:240)(cid:239)Øηθ(cid:229)(cid:221) µ(cid:229) (cid:244)ην (cid:239)(cid:228)ηγ(cid:221)Æ 97/56/ΕΚ (cid:244)(cid:239)υ Ευρω(cid:240)Æϊκ(cid:239)υ(cid:139) Κ(cid:239)Øν(cid:239)(cid:226)(cid:239)υλ(cid:221)(cid:239)υ κÆØ (cid:244)(cid:239)υ Συµ(cid:226)(cid:239)υλ(cid:221)(cid:239)υ (9) γØÆ (cid:244)η (cid:228)(cid:229)(cid:139) κÆ(cid:244)η (cid:229)(cid:139) κ(cid:244)η (cid:244)ρ(cid:239)(cid:240)(cid:239)(cid:240)(cid:239)(cid:221)η(cid:243)η (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 76/769/ΕˆΚﬂ (5) (6) (5) ΕΕ L 365 (cid:244)ης 31. 12. 1994, (cid:243). 1. (6) ΕΕ L 262 (cid:244)ης 27. 9. 1976, (cid:243). 201ﬂ (cid:239)(cid:228)ηγ(cid:221)Æ (cid:222)(cid:240)ως (cid:244)ρ(cid:239)(cid:240)(cid:239)(cid:240)(cid:239)Øη(cid:139) θηκ(cid:229) (cid:244)(cid:229)λ(cid:229)υ(cid:244)Æ(cid:221)Æ Æ(cid:240)(cid:222) (cid:244)ην (cid:239)(cid:228)ηγ(cid:221)Æ 97/64/ΕΚ (cid:244)ης Ε(cid:240)Ø(cid:244)ρ(cid:239)(cid:240)η(cid:139) ς (ΕΕ L 315 (cid:244)ης 19. 11. 1997, (cid:243). 13). (7) ˆ(cid:228)ηγ(cid:221)Æ 67/548/ΕˆΚ (cid:244)(cid:239)υ Συµ(cid:226)(cid:239)υλ(cid:221)(cid:239)υ, (cid:244)ης 27ης Ι(cid:239)υν(cid:221)(cid:239)υ 1967, (cid:240)(cid:229)ρ(cid:221) (cid:240)ρ(cid:239)(cid:243)(cid:229)γγ(cid:221)(cid:243)(cid:229)ως (cid:244)ων ν(cid:239)µ(cid:239)θ(cid:229)(cid:244)Øκω(cid:139) ν, κÆν(cid:239)νØ(cid:243)(cid:244)Øκω(cid:139) ν κÆØ (cid:228)Ø(cid:239)Øκη- (cid:244)Øκω(cid:139) ν (cid:228)ØÆ(cid:244)(cid:192)Œ(cid:229)ων (cid:240)(cid:229)ρ(cid:221) (cid:244)ÆŒØν(cid:239)µη(cid:139) (cid:243)(cid:229)ως, (cid:243)υ(cid:243)κ(cid:229)υÆ(cid:243)(cid:221)Æς κÆØ (cid:229)(cid:240)Ø(cid:243)η- µ(cid:192)ν(cid:243)(cid:229)ως (cid:244)ων (cid:229)(cid:240)ØκØν(cid:228)υ(cid:139) νων (cid:239)υ(cid:243)Øω(cid:139) ν (ΕΕ 196 (cid:244)ης 16. 8. 1967, (cid:243). 1)ﬂ (cid:239)(cid:228)ηγ(cid:221)Æ (cid:222)(cid:240)ως (cid:244)ρ(cid:239)(cid:240)(cid:239)(cid:240)(cid:239)Øη(cid:139) θηκ(cid:229) (cid:244)(cid:229)λ(cid:229)υ(cid:244)Æ(cid:221)Æ Æ(cid:240)(cid:222) (cid:244)ην (cid:239)(cid:228)ηγ(cid:221)Æ 97/ 69/ΕΚ (cid:244)ης Ε(cid:240)Ø(cid:244)ρ(cid:239)(cid:240)η(cid:139) ς (ΕΕ L 343 (cid:244)ης 13. 12. 1997, (cid:243). 19). (8) ΕΕ L 248 (cid:244)ης 30. 9. 1996, (cid:243). 1. (9) ΕΕ L 333 (cid:244)ης 4. 12. 1997, (cid:243). 1. C 18/44 EL Ε(cid:240)(cid:221)(cid:243)ηµη Ε(cid:230)ηµ(cid:229)ρ(cid:221)(cid:228)Æ (cid:244)ων Ευρω(cid:240)Æϊκω(cid:139) ν Κ(cid:239)Øν(cid:239)(cid:244)η(cid:139) (cid:244)ων 22. 1. 1999 (7) (8) (9) (cid:222)(cid:244)Ø (cid:239)Ø κ(cid:221)ν(cid:228)υν(cid:239)Ø κÆØ (cid:244)Æ (cid:240)λ(cid:229)(cid:239)ν(cid:229)κ(cid:244)η(cid:139) µÆ(cid:244)Æ (cid:244)ων (cid:239)υ(cid:243)Øω(cid:139) ν (cid:240)(cid:239)υ (cid:240)ρ(cid:222)(cid:243)(cid:230)Æ(cid:244)Æ (cid:244)ÆŒØν(cid:239)µη(cid:139) θηκÆν, µ(cid:229) (cid:244)ην (cid:239)(cid:228)ηγ(cid:221)Æ 96/ 54/ΕΚ, ως κÆρκØν(cid:239)γ(cid:222)ν(cid:229)ς, µ(cid:229)(cid:244)ÆλλÆŒØγ(cid:222)ν(cid:229)ς κÆØ (cid:244)(cid:239)ŒØκ(cid:229)(cid:139) ς γØÆ (cid:244)ην ÆνÆ(cid:240)ÆρÆγωγη(cid:139) , κÆ(cid:244)ηγ(cid:239)ρ(cid:221)Æς 1 η(cid:139) 2 (cid:229)(cid:139) ł(cid:239)υν λη(cid:230)θ(cid:229)(cid:221) υ(cid:240)(cid:222)ψηﬂ (cid:222)(cid:244)Ø µ(cid:229) (cid:244)(cid:239) (cid:192)ρθρ(cid:239) 1 (cid:243)ηµ(cid:229)(cid:221)(cid:239) 1 (cid:243)(cid:244)(cid:239)Øł(cid:229)(cid:221)(cid:239) (cid:243)(cid:244)) (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 96/54/ΕΚ Æ(cid:240)Æλ(cid:229)(cid:221)(cid:230)θηκÆν (cid:239)κ(cid:244)ω(cid:139) κÆ(cid:244)Æłωρη(cid:139) (cid:243)(cid:229)Øς (cid:243)(cid:244)(cid:239) (cid:240)Æρ(cid:192)ρ(cid:244)ηµÆ I (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 67/548/ΕˆΚ, (cid:229)(cid:240)(cid:229)Ø(cid:228)η(cid:139) (cid:239)Ø κÆ(cid:244)Æłωρη(cid:139) (cid:243)(cid:229)Øς Æυ(cid:244)(cid:229)(cid:139) ς Æ(cid:230)(cid:239)ρ(cid:239)υ(cid:139) ν (cid:239)υ(cid:243)(cid:221)(cid:229)ς (cid:240)(cid:239)υ κÆλυ(cid:139) (cid:240)(cid:244)(cid:239)ν- (cid:244)ÆØ η(cid:139) (cid:228)η Æ(cid:240)(cid:222) (cid:192)λλ(cid:229)ς κÆ(cid:244)Æłωρη(cid:139) (cid:243)(cid:229)Øς η(cid:139) (cid:244)ων (cid:239)(cid:240)(cid:239)(cid:221)ων (cid:229)(cid:139) ł(cid:229)Ø Æ(cid:240)Æλ(cid:229)Ø(cid:230)θ(cid:229)(cid:221) η (cid:244)ÆŒØν(cid:222)µη(cid:243)η ως κÆρκØν(cid:239)γ(cid:222)νων (cid:239)υ(cid:243)Øω(cid:139) νﬂ (cid:222)(cid:244)Ø (cid:240)(cid:229)(cid:139) ν(cid:244)(cid:229) Æ(cid:240)(cid:222) (cid:244)Øς (cid:239)υ(cid:243)(cid:221)(cid:229)ς Æυ(cid:244)(cid:229)(cid:139) ς (cid:240)(cid:229)ρØλÆµ(cid:226)(cid:192)ν(cid:239)ν(cid:244)ÆØ (cid:243)(cid:244)(cid:239) (cid:240)ρ(cid:239)(cid:243)(cid:192)ρ(cid:244)ηµÆ (cid:244)(cid:239)υ (cid:243)ηµ(cid:229)(cid:221)(cid:239)υ 29 (cid:244)(cid:239)υ (cid:240)ÆρÆρ(cid:244)η(cid:139) µÆ(cid:244)(cid:239)ς I (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 76/769/ΕˆΚﬂ (cid:222)(cid:244)Ø, κÆ(cid:244)(cid:192) (cid:243)υν(cid:229)(cid:139) (cid:240)(cid:229)ØÆ, (cid:239)Ø κÆ(cid:244)Æłωρη(cid:139) (cid:243)(cid:229)Øς Æυ(cid:244)(cid:229)(cid:139) ς θÆ (cid:240)ρ(cid:229)(cid:139) (cid:240)(cid:229)Ø (cid:229)(cid:240)(cid:221)(cid:243)ης νÆ ÆνÆλ(cid:229)Ø(cid:230)- θ(cid:239)υ(cid:139) ν, (cid:243)’ Æυ(cid:244)η(cid:139) (cid:244)ην (cid:244)(cid:229)λ(cid:229)υ(cid:244)Æ(cid:221)Æ (cid:239)(cid:228)ηγ(cid:221)Æﬂ (cid:222)(cid:244)Ø η (cid:240)Æρ(cid:239)υ(cid:139) (cid:243)Æ (cid:239)(cid:228)ηγ(cid:221)Æ Ø(cid:243)łυ(cid:139) (cid:229)Ø υ(cid:240)(cid:222) (cid:244)ην (cid:229)(cid:240)Ø(cid:230)υ(cid:139) λÆŒη (cid:244)ης κ(cid:239)Øν(cid:239)(cid:244)Øκη(cid:139) ς ν(cid:239)µ(cid:239)θ(cid:229)(cid:243)(cid:221)Æς (cid:240)(cid:239)υ κÆθ(cid:239)ρ(cid:221)œ(cid:229)Ø (cid:229)λ(cid:192)łØ(cid:243)(cid:244)(cid:229)ς Æ(cid:240)ÆØ(cid:244)η(cid:139) (cid:243)(cid:229)Øς γØÆ (cid:244)ην (cid:240)ρ(cid:239)(cid:243)(cid:244)Æ(cid:243)(cid:221)Æ (cid:244)ων (cid:229)ργÆœ(cid:239)µ(cid:229)(cid:139) νων, κÆØ η (cid:239)(cid:240)(cid:239)(cid:221)Æ (cid:240)ρ(cid:239)(cid:226)λ(cid:229)(cid:139) (cid:240)(cid:229)(cid:244)ÆØ (cid:243)(cid:244)ην (cid:239)(cid:228)ηγ(cid:221)Æ 89/391/ΕˆΚ (cid:244)(cid:239)υ Συµ(cid:226)(cid:239)υλ(cid:221)(cid:239)υ, (cid:244)ης 12ης Ι(cid:239)υν(cid:221)(cid:239)υ 1989, (cid:243)ł(cid:229)(cid:244)Øκ(cid:192) µ(cid:229) (cid:244)ην (cid:229)(cid:230)Æρµ(cid:239)γη(cid:139) µ(cid:229)(cid:139) (cid:244)ρων γØÆ (cid:244)ην (cid:240)ρ(cid:239)ω(cid:139) θη(cid:243)η (cid:244)ης (cid:226)(cid:229)λ(cid:244)(cid:221)ω(cid:243)ης (cid:244)ης Æ(cid:243)(cid:230)(cid:192)λ(cid:229)ØÆς κÆØ (cid:244)ης υγ(cid:229)(cid:221)Æς (cid:244)ων (cid:229)ργÆœ(cid:239)µ(cid:229)(cid:139) νων κÆ(cid:244)(cid:192) (cid:244)ην (cid:229)ργÆ(cid:243)(cid:221)Æ (1), κÆθω(cid:139) ς κÆØ (cid:243)(cid:244)Øς (cid:229)(cid:240)Øµ(cid:229)(cid:139) ρ(cid:239)υς (cid:239)(cid:228)η- γ(cid:221)(cid:229)ς (cid:240)(cid:239)υ (cid:226)Æ(cid:243)(cid:221)œ(cid:239)ν(cid:244)ÆØ (cid:243)’ Æυ(cid:244)η(cid:139) ν, Ø(cid:228)(cid:221)ως (cid:243)(cid:244)ην (cid:239)(cid:228)ηγ(cid:221)Æ 90/394/ΕˆΚ (cid:244)(cid:239)υ Συµ(cid:226)(cid:239)υλ(cid:221)(cid:239)υ, (cid:244)ης 28ης Ι(cid:239)υν(cid:221)(cid:239)υ 1990, (cid:243)ł(cid:229)(cid:244)Øκ(cid:192) µ(cid:229) (cid:244)ην (cid:240)ρ(cid:239)(cid:243)(cid:244)Æ(cid:243)(cid:221)Æ (cid:244)ων (cid:229)ργÆœ(cid:239)µ(cid:229)(cid:139) νων Æ(cid:240)(cid:222) (cid:244)(cid:239)υς κØν(cid:228)υ(cid:139) ν(cid:239)υς (cid:240)(cid:239)υ (cid:243)υν(cid:228)(cid:229)(cid:139) (cid:239)ν(cid:244)ÆØ µ(cid:229) (cid:244)ην (cid:229)(cid:139) κθ(cid:229)(cid:243)η (cid:243)(cid:229) κÆρκØν(cid:239)γ(cid:222)ν(cid:239)υς (cid:240)Æρ(cid:192)γ(cid:239)ν(cid:244)(cid:229)ς κÆ(cid:244)(cid:192) (cid:244)ην (cid:229)ργÆ(cid:243)(cid:221)Æ ((cid:229)(cid:139) κ(cid:244)η (cid:229)Ø(cid:228)Øκη(cid:139) (cid:239)(cid:228)ηγ(cid:221)Æ κÆ(cid:244)(cid:192) (cid:244)ην (cid:229)(cid:139) νν(cid:239)ØÆ (cid:244)(cid:239)υ (cid:192)ρθρ(cid:239)υ 16 (cid:240)Æρ(cid:192)γρÆ(cid:230)(cid:239)ς 1 (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 89/391/ΕˆΚ) (2), ˝ρθρ(cid:239) 2 ˆØ (cid:239)υ(cid:243)(cid:221)(cid:229)ς (cid:240)(cid:239)υ Æ(cid:240)ÆρØθµ(cid:239)υ(cid:139) ν(cid:244)ÆØ (cid:243)(cid:244)(cid:239) (cid:240)Æρ(cid:192)ρ(cid:244)ηµÆ II (cid:244)ης (cid:240)Æρ(cid:239)υ(cid:139) (cid:243)Æς (cid:239)(cid:228)ηγ(cid:221)Æς Æ(cid:240)Æλ(cid:229)(cid:221)(cid:230)θηκÆν Æ(cid:240)(cid:222) (cid:244)(cid:239)ν κÆ(cid:244)(cid:192)λ(cid:239)γ(cid:239) (cid:244)ων (cid:239)υ(cid:243)Øω(cid:139) ν (cid:240)(cid:239)υ (cid:229)(cid:139) ł(cid:229)Ø (cid:240)(cid:229)ρØλη(cid:230)θ(cid:229)(cid:221) (cid:243)(cid:244)(cid:239) (cid:240)ρ(cid:239)(cid:243)(cid:192)ρ(cid:244)ηµÆ (cid:244)(cid:239)υ (cid:243)ηµ(cid:229)(cid:221)(cid:239)υ 29 (cid:244)(cid:239)υ (cid:240)ÆρÆρ(cid:244)η(cid:139) µÆ(cid:244)(cid:239)ς I (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 76/769/ΕˆΚ. ˝ρθρ(cid:239) 3 1. ΤÆ κρ(cid:192)(cid:244)η µ(cid:229)(cid:139) λη θ(cid:229)(cid:243)(cid:240)(cid:221)œ(cid:239)υν κÆØ (cid:228)ηµ(cid:239)(cid:243)Ø(cid:229)υ(cid:139) (cid:239)υν (cid:244)Øς ν(cid:239)µ(cid:239)θ(cid:229)- (cid:244)Øκ(cid:229)(cid:139) ς, κÆν(cid:239)νØ(cid:243)(cid:244)Øκ(cid:229)(cid:139) ς κÆØ (cid:228)Ø(cid:239)Øκη(cid:244)Øκ(cid:229)(cid:139) ς (cid:228)ØÆ(cid:244)(cid:192)Œ(cid:229)Øς (cid:240)(cid:239)υ Æ(cid:240)ÆØ(cid:244)(cid:239)υ(cid:139) - ν(cid:244)ÆØ γØÆ (cid:244)η (cid:243)υµµ(cid:222)ρ(cid:230)ω(cid:243)η(cid:139) (cid:244)(cid:239)υς (cid:240)ρ(cid:239)ς (cid:244)ην (cid:240)Æρ(cid:239)υ(cid:139) (cid:243)Æ (cid:239)(cid:228)ηγ(cid:221)Æ, (cid:244)(cid:239) Æργ(cid:222)(cid:244)(cid:229)ρ(cid:239) (cid:229)(cid:139) νÆ (cid:229)(cid:139) (cid:244)(cid:239)ς µ(cid:229)(cid:244)(cid:192) (cid:244)ην ηµ(cid:229)ρ(cid:239)µην(cid:221)Æ (cid:244)ης (cid:229)ν(cid:192)ρŒ(cid:229)ως Ø(cid:243)łυ(cid:139) (cid:239)ς (cid:244)ης. Πληρ(cid:239)(cid:230)(cid:239)ρ(cid:239)υ(cid:139) ν Æµ(cid:229)(cid:139) (cid:243)ως (cid:244)ην Ε(cid:240)Ø(cid:244)ρ(cid:239)(cid:240)η(cid:139) (cid:243)ł(cid:229)(cid:244)Øκ(cid:192). Ε(cid:230)Æρµ(cid:222)œ(cid:239)υν (cid:244)Øς (cid:228)ØÆ(cid:244)(cid:192)Œ(cid:229)Øς Æυ(cid:244)(cid:229)(cid:139) ς 18 µη(cid:139) ν(cid:229)ς µ(cid:229)(cid:244)(cid:192) (cid:244)ην ηµ(cid:229)ρ(cid:239)- µην(cid:221)Æ (cid:229)ν(cid:192)ρŒ(cid:229)ως Ø(cid:243)łυ(cid:139) (cid:239)ς (cid:244)ης (cid:240)Æρ(cid:239)υ(cid:139) (cid:243)Æς (cid:239)(cid:228)ηγ(cid:221)Æς. 2. ˆØ (cid:228)ØÆ(cid:244)(cid:192)Œ(cid:229)Øς Æυ(cid:244)(cid:229)(cid:139) ς, (cid:222)(cid:244)Æν θ(cid:229)(cid:243)(cid:240)(cid:221)œ(cid:239)ν(cid:244)ÆØ Æ(cid:240)(cid:222) (cid:244)Æ κρ(cid:192)(cid:244)η µ(cid:229)(cid:139) λη, ÆνÆ(cid:230)(cid:229)(cid:139) ρ(cid:239)ν(cid:244)ÆØ (cid:243)(cid:244)ην (cid:240)Æρ(cid:239)υ(cid:139) (cid:243)Æ (cid:239)(cid:228)ηγ(cid:221)Æ η(cid:139) (cid:243)υν(cid:239)(cid:228)(cid:229)υ(cid:139) (cid:239)ν(cid:244)ÆØ Æ(cid:240)(cid:222) (cid:244)ην ÆνÆ(cid:230)(cid:239)ρ(cid:192) Æυ(cid:244)η(cid:139) κÆ(cid:244)(cid:192) (cid:244)ην (cid:229)(cid:240)(cid:221)(cid:243)ηµη (cid:228)ηµ(cid:239)(cid:243)(cid:221)(cid:229)υ(cid:243)η(cid:139) (cid:244)(cid:239)υς. ˆØ λ(cid:229)(cid:240)(cid:244)(cid:239)µ(cid:229)ρ(cid:229)(cid:221)ς (cid:228)ØÆ(cid:244)(cid:192)Œ(cid:229)Øς (cid:244)ης ÆνÆ(cid:230)(cid:239)ρ(cid:192)ς Æυ(cid:244)η(cid:139) ς κÆθ(cid:239)- ρ(cid:221)œ(cid:239)ν(cid:244)ÆØ Æ(cid:240)(cid:222) (cid:244)Æ κρ(cid:192)(cid:244)η µ(cid:229)(cid:139) λη. ˝ρθρ(cid:239) 4 Η (cid:240)Æρ(cid:239)υ(cid:139) (cid:243)Æ (cid:239)(cid:228)ηγ(cid:221)Æ Æρł(cid:221)œ(cid:229)Ø νÆ Ø(cid:243)łυ(cid:139) (cid:229)Ø (cid:244)ην ηµ(cid:229)(cid:139) ρÆ (cid:244)ης (cid:228)ηµ(cid:239)- (cid:243)(cid:221)(cid:229)υ(cid:243)η(cid:139) ς (cid:244)ης (cid:243)(cid:244)ην Ε(cid:240)(cid:221)(cid:243)ηµη Ε(cid:230)ηµ(cid:229)ρ(cid:221)(cid:228)Æ (cid:244)ων Ευρω(cid:240)Æϊκω(cid:139) ν Κ(cid:239)Øν(cid:239)(cid:244)η(cid:139) (cid:244)ων. ˝ρθρ(cid:239) 5 Ε¥Ε∆ΩΣΑΝ ΤΗΝ ΠΑΡˆΥΣΑ ˆ∆ΗΓΙΑ: Η (cid:240)Æρ(cid:239)υ(cid:139) (cid:243)Æ (cid:239)(cid:228)ηγ(cid:221)Æ Æ(cid:240)(cid:229)υθυ(cid:139) ν(cid:229)(cid:244)ÆØ (cid:243)(cid:244)Æ κρ(cid:192)(cid:244)η µ(cid:229)(cid:139) λη. ˝ρθρ(cid:239) 1 ˆØ (cid:239)υ(cid:243)(cid:221)(cid:229)ς (cid:240)(cid:239)υ Æ(cid:240)ÆρØθµ(cid:239)υ(cid:139) ν(cid:244)ÆØ (cid:243)(cid:244)(cid:239) (cid:240)Æρ(cid:192)ρ(cid:244)ηµÆ I (cid:244)ης (cid:240)Æρ(cid:239)υ(cid:139) - (cid:243)Æς (cid:239)(cid:228)ηγ(cid:221)Æς (cid:240)ρ(cid:239)(cid:243)(cid:244)(cid:221)θ(cid:229)ν(cid:244)ÆØ (cid:243)(cid:244)Øς (cid:239)υ(cid:243)(cid:221)(cid:229)ς (cid:240)(cid:239)υ (cid:240)(cid:229)ρØλÆµ(cid:226)(cid:192)ν(cid:239)- ν(cid:244)ÆØ (cid:243)(cid:244)(cid:239) (cid:240)ρ(cid:239)(cid:243)(cid:192)ρ(cid:244)ηµÆ (cid:244)ων (cid:243)ηµ(cid:229)(cid:221)ων 29, 30 κÆØ 31 (cid:244)(cid:239)υ (cid:240)ÆρÆρ(cid:244)η(cid:139) µÆ(cid:244)(cid:239)ς I (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 76/769/ΕˆΚ. , ΓØÆ (cid:244)(cid:239) Ευρω(cid:240)Æϊκ(cid:222) Κ(cid:239)Øν(cid:239)(cid:226)(cid:239)υ(cid:139) λØ(cid:239) ΓØÆ (cid:244)(cid:239) Συµ(cid:226)(cid:239)υ(cid:139) λØ(cid:239) ˆ Πρ(cid:222)(cid:229)(cid:228)ρ(cid:239)ς ˆ Πρ(cid:222)(cid:229)(cid:228)ρ(cid:239)ς (1) ΕΕ L 183 (cid:244)ης 29. 6. 1989, (cid:243). 1. (2) ΕΕ L 196 (cid:244)ης 26. 7. 1990, (cid:243). 1. 22. 1. 1999 EL Ε(cid:240)(cid:221)(cid:243)ηµη Ε(cid:230)ηµ(cid:229)ρ(cid:221)(cid:228)Æ (cid:244)ων Ευρω(cid:240)Æϊκω(cid:139) ν Κ(cid:239)Øν(cid:239)(cid:244)η(cid:139) (cid:244)ων C 18/45 ΠΑΡΑΡΤΗΜΑ I Σηµ(cid:229)(cid:221)(cid:239) 29 — ΚÆρκØν(cid:239)γ(cid:222)ν(cid:229)ς (cid:239)υ(cid:243)(cid:221)(cid:229)ς: κÆ(cid:244)ηγ(cid:239)ρ(cid:221)Æ 2 ˆυ(cid:243)(cid:221)(cid:229)ς ΑρØθµ(cid:222)ς κÆ(cid:244)Æλ(cid:222)γ(cid:239)υ ΑρØθµ(cid:222)ς ΕΚ ΑρØθµ(cid:222)ς CAS Σηµ(cid:229)(cid:221)ω(cid:243)η ∆ØłρωµØκ(cid:222) κ(cid:192)λØ(cid:239) ∆ØłρωµØκ(cid:222) Æµµω(cid:139) νØ(cid:239) ∆ØłρωµØκ(cid:222) ν(cid:192)(cid:244)ρØ(cid:239) ∆ØłρωµØκ(cid:222) ν(cid:192)(cid:244)ρØ(cid:239), (cid:228)Ø(cid:229)(cid:139) νυ(cid:228)ρ(cid:239) ∆ØłλωρØ(cid:239)υ(cid:139) ł(cid:239) łρωµυ(cid:139) λØ(cid:239) (cid:204)ρωµØκ(cid:222) κ(cid:192)λØ(cid:239) Ενω(cid:139) (cid:243)(cid:229)Øς łρωµ(cid:221)(cid:239)υ (VI), (cid:229)κ(cid:244)(cid:222)ς (cid:244)(cid:239)υ łρωµØκ(cid:239)υ(cid:139) (cid:226)Æρ(cid:221)(cid:239)υ κÆØ (cid:244)ων (cid:229)νω(cid:139) (cid:243)(cid:229)- ων (cid:240)(cid:239)υ κÆ(cid:244)(cid:239)ν(cid:239)µ(cid:192)œ(cid:239)ν(cid:244)ÆØ (cid:243)(cid:229) (cid:192)λλ(cid:239) (cid:243)ηµ(cid:229)(cid:221)(cid:239) (cid:244)(cid:239)υ (cid:240)ÆρÆρ(cid:244)η(cid:139) µÆ(cid:244)(cid:239)ς I (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 67/548/ΕˆΚ Βρωµ(cid:239)ÆØθυλ(cid:229)(cid:139) νØ(cid:239) 5-Æλλυλ(cid:239)-1,3-(cid:226)(cid:229)νœ(cid:239)(cid:228)Ø(cid:239)Œ(cid:222)λη, (cid:243)Æ(cid:230)ρ(cid:222)λη Αœωłρω(cid:243)(cid:244)Øκ(cid:229)(cid:139) ς µ(cid:229) (cid:226)(cid:192)(cid:243)η (cid:226)(cid:229)νœØ(cid:228)(cid:221)νη, łρω(cid:243)(cid:244)Øκ(cid:229)(cid:139) ς 4,4(cid:57)-(cid:228)ØÆρυλÆœω- (cid:228)Ø(cid:230)ÆØνυλ(cid:221)(cid:239)υ, (cid:229)κ(cid:244)(cid:222)ς (cid:229)κ(cid:229)(cid:221)νων (cid:240)(cid:239)υ κÆ(cid:244)(cid:239)ν(cid:239)µ(cid:192)œ(cid:239)ν(cid:244)ÆØ (cid:243)(cid:229) (cid:192)λλ(cid:239) (cid:243)ηµ(cid:229)(cid:221)(cid:239) (cid:244)(cid:239)υ (cid:240)ÆρÆρ(cid:244)η(cid:139) µÆ(cid:244)(cid:239)ς I (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 67/548/ΕˆΚ 4-ÆµØν(cid:239) 3-[[4(cid:57)-[(2,4-(cid:228)ØÆµ(cid:239)ν(cid:239)(cid:230)ÆØνυλ)Æœω][1,1(cid:57)-(cid:228)Ø(cid:230)ÆØνυλ]-4-υλ]Æœω]-5- υ(cid:228)ρ(cid:239)Œυ-6-((cid:230)ÆØνυλÆœω)νÆ(cid:230)θÆλ(cid:229)ν(cid:239)-2,7-(cid:228)Ø(cid:243)(cid:239)υλ(cid:230)(cid:239)νØκ(cid:222) (cid:228)Øν(cid:192)(cid:244)ρØ(cid:239)ﬂ C. I. Direct Black 38 3,3(cid:57)-[[1,1(cid:57)-(cid:228)Ø(cid:230)ÆØνυλ(cid:239)]-4,4(cid:57)-(cid:228)Øυλ(cid:239)(cid:228)Øς(Æœω)(cid:228)Øς[5-ÆµØν(cid:239)-4-υ(cid:228)ρ(cid:239)ŒυνÆ(cid:230)- θÆλ(cid:229)ν(cid:239)-2,7-(cid:228)Ø(cid:243)(cid:239)υλ(cid:230)(cid:239)νØκ(cid:222)] (cid:244)(cid:229)(cid:244)ρÆν(cid:192)(cid:244)ρØ(cid:239)ﬂ C. I. Direct Blue 6 3,3(cid:57)-[[1,1(cid:57)-(cid:228)Ø(cid:230)ÆØνυλ(cid:239)]-4,-4(cid:57)(cid:228)Øυλ(cid:239)(cid:228)Øς(Æœω)](cid:228)Øς(4-ÆµØν(cid:239)νÆ(cid:230)θÆλ(cid:229)ν(cid:239)-1- (cid:243)(cid:239)υλ(cid:230)(cid:239)νØκ(cid:222)) (cid:228)Øν(cid:192)(cid:244)ρØ(cid:239)ﬂ C. I. Direct Red 28 Θ(cid:229)ØØκ(cid:222) (cid:244)(cid:239)λ(cid:239)υ(cid:229)ν(cid:239)-2,4-(cid:228)ØÆµµω(cid:139) νØ(cid:239) 024-002-00-6 231-906-6 024-003-00-1 232-143-1 024-004-00-7 234-190-3 024-004-01-4 234-190-3 024-005-00-2 239-056-8 024-006-00-8 232-140-5 024-017-00-8 — 7778-50-9 7789-09-5 10588-01-9 7789-12-0 14977-61-8 7789-00-6 — 602-024-00-2 209-800-6 605-020-00-9 202-345-4 611-024-00-1 — 593-60-2 94-59-7 — 611-025-00-7 217-710-3 1937-37-7 611-026-00-2 220-012-1 2602-46-2 611-027-00-8 209-358-4 573-58-0 612-126-00-9 265-697-8 65321-67-7 Σηµ(cid:229)(cid:221)(cid:239) 30 — Μ(cid:229)(cid:244)ÆλλÆŒØγ(cid:222)ν(cid:229)ς (cid:239)υ(cid:243)(cid:221)(cid:229)ς: κÆ(cid:244)ηγ(cid:239)ρ(cid:221)Æ 2 ˆυ(cid:243)(cid:221)(cid:229)ς ΑρØθµ(cid:222)ς κÆ(cid:244)Æλ(cid:222)γ(cid:239)υ ΑρØθµ(cid:222)ς ΕΚ ΑρØθµ(cid:222)ς CAS Σηµ(cid:229)(cid:221)ω(cid:243)η ∆ØłρωµØκ(cid:222) κ(cid:192)λØ(cid:239) ∆ØłρωµØκ(cid:222) Æµµω(cid:139) νØ(cid:239) ∆ØłρωµØκ(cid:222) ν(cid:192)(cid:244)ρØ(cid:239) ∆ØłρωµØκ(cid:222) ν(cid:192)(cid:244)ρØ(cid:239), (cid:228)Ø(cid:229)(cid:139) νυ(cid:228)ρ(cid:239) ∆ØłλωρØ(cid:239)υ(cid:139) ł(cid:239) łρωµυ(cid:139) λØ(cid:239) (cid:204)ρωµØκ(cid:222) κ(cid:192)λØ(cid:239) 1,3,5-(cid:244)ρØς((cid:239)ŒØρÆνυλ(cid:239)µ(cid:229)θυλ(cid:239))-1,3,5-(cid:244)ρØÆœØν(cid:239)-2,4,6(1H, 3H, 5H)-(cid:244)ρØ(cid:222)- νη: TGIC 024-002-00-6 231-906-6 024-003-00-1 232-143-1 024-004-00-7 234-190-3 024-004-01-4 234-190-3 024-005-00-2 239-056-8 024-006-00-8 232-140-5 615-021-00-6 219-514-3 7778-50-9 7789-09-5 10588-01-9 7789-12-0 14977-61-8 7789-00-6 2451-62-9 Σηµ(cid:229)(cid:221)(cid:239) 31 — ˆυ(cid:243)(cid:221)(cid:229)ς (cid:244)(cid:239)ŒØκ(cid:229)(cid:139) ς γØÆ (cid:244)ην ÆνÆ(cid:240)ÆρÆγωγη(cid:139) : κÆ(cid:244)ηγ(cid:239)ρ(cid:221)Æ 1 ˆυ(cid:243)(cid:221)(cid:229)ς ΑρØθµ(cid:222)ς κÆ(cid:244)Æλ(cid:222)γ(cid:239)υ ΑρØθµ(cid:222)ς ΕΚ ΑρØθµ(cid:222)ς CAS Σηµ(cid:229)(cid:221)ω(cid:243)η 1,2-(cid:228)Ø(cid:226)ρωµ(cid:239)-3-łλωρ(cid:239)(cid:240)ρ(cid:239)(cid:240)(cid:192)νØ(cid:239) 602-021-00-6 202-479-3 96-12-8 Σηµ(cid:229)(cid:221)(cid:239) 31 — ˆυ(cid:243)(cid:221)(cid:229)ς (cid:244)(cid:239)ŒØκ(cid:229)(cid:139) ς γØÆ (cid:244)ην ÆνÆ(cid:240)ÆρÆγωγη(cid:139) : κÆ(cid:244)ηγ(cid:239)ρ(cid:221)Æ 2 ˆυ(cid:243)(cid:221)(cid:229)ς ΑρØθµ(cid:222)ς κÆ(cid:244)Æλ(cid:222)γ(cid:239)υ ΑρØθµ(cid:222)ς ΕΚ ΑρØθµ(cid:222)ς CAS Σηµ(cid:229)(cid:221)ω(cid:243)η ΦθÆλØκ(cid:222) (cid:228)Øς(2-µ(cid:229)θ(cid:239)ŒυÆØθυ(cid:139) λØ(cid:239)) 607-228-00-5 204-212-6 117-82-8 C 18/46 EL Ε(cid:240)(cid:221)(cid:243)ηµη Ε(cid:230)ηµ(cid:229)ρ(cid:221)(cid:228)Æ (cid:244)ων Ευρω(cid:240)Æϊκω(cid:139) ν Κ(cid:239)Øν(cid:239)(cid:244)η(cid:139) (cid:244)ων 22. 1. 1999 ΠΑΡΑΡΤΗΜΑ II ˆυ(cid:243)(cid:221)(cid:229)ς ΑρØθµ(cid:222)ς κÆ(cid:244)Æλ(cid:222)γ(cid:239)υ ΑρØθµ(cid:222)ς ΕΚ ΑρØθµ(cid:222)ς CAS Σηµ(cid:229)(cid:221)ω(cid:243)η ΑρωµÆ(cid:244)Øκ(cid:239)(cid:221) υ(cid:228)ρ(cid:239)γ(cid:239)ν(cid:192)νθρÆκ(cid:229)ς C8-10. Ε(cid:240)ÆνÆ(cid:240)(cid:222)(cid:243)(cid:244)ÆγµÆ (cid:229)λÆ(cid:230)ρω(cid:139) ν (cid:229)λÆ(cid:221)ων, υψηλ(cid:239)υ(cid:139) (cid:243)ηµ(cid:229)(cid:221)(cid:239)υ œ(cid:229)(cid:139) (cid:243)ης 648-011-00-5 292-695-4 90989-39-2 Π(cid:221)(cid:243)(cid:243)Æ λØγν(cid:221)(cid:244)η, (cid:230)ÆØν(cid:239)λØκ(cid:222) (cid:229)(cid:139) λÆØ(cid:239) 648-025-00-1 309-885-0 101316-83-0 J J [˛λÆØ(cid:239) (cid:240)(cid:239)υ Æ(cid:240)(cid:239)(cid:243)(cid:244)(cid:192)œ(cid:229)(cid:244)ÆØ Æ(cid:240)(cid:222) (cid:240)(cid:221)(cid:243)(cid:243)Æ λØγν(cid:221)(cid:244)η. Α(cid:240)(cid:239)(cid:244)(cid:229)λ(cid:229)(cid:221)(cid:244)ÆØ κυρ(cid:221)ως Æ(cid:240)(cid:222) Æλ(cid:229)Ø(cid:230)Æ(cid:244)Øκ(cid:239)υ(cid:139) ς, νÆ(cid:230)θ(cid:229)νØκ(cid:239)υ(cid:139) ς κÆØ ÆρωµÆ(cid:244)Øκ(cid:239)υ(cid:139) ς υ(cid:228)ρ(cid:239)γ(cid:239)ν(cid:192)νθρÆ- κ(cid:229)ς µ(cid:229) (cid:229)(cid:139) νÆ ως (cid:244)ρ(cid:229)Øς (cid:228)Æκ(cid:244)υλ(cid:221)(cid:239)υς, Æλκυλ(cid:239)(cid:240)Æρ(cid:192)γωγ(cid:192) (cid:244)(cid:239)υς, (cid:229)(cid:244)(cid:229)ρ(cid:239)Æρω- µÆ(cid:244)Øκ(cid:192) κÆØ (cid:230)ÆØν(cid:222)λ(cid:229)ς µ(cid:229) (cid:229)(cid:139) νÆ κÆØ (cid:228)υ(cid:139) (cid:239) (cid:228)Æκ(cid:244)υλ(cid:221)(cid:239)υς, µ(cid:229) (cid:240)(cid:229)ρØ(cid:239)łη(cid:139) (cid:226)ρÆ- (cid:243)µ(cid:239)υ(cid:139) Æ(cid:240)(cid:222) 150° C ως 360° C (cid:240)(cid:229)ρ(cid:221)(cid:240)(cid:239)υ] Κ(cid:239)κ (ÆνθρÆκ(cid:222)(cid:240)Ø(cid:243)(cid:243)Æ), κÆ(cid:244)ρ(cid:192)µØ υψηλη(cid:139) ς θ(cid:229)ρµ(cid:239)κρÆ(cid:243)(cid:221)Æς Κ(cid:239)κ (ÆνθρÆκ(cid:222)(cid:240)Ø(cid:243)(cid:243)Æ), µ(cid:229) Æν(cid:192)µ(cid:229)ØŒη µ(cid:229) κÆ(cid:244)ρ(cid:192)µØ υψηλη(cid:139) ς θ(cid:229)ρµ(cid:239)κρÆ(cid:243)(cid:221)- Æς 648-157-00-(cid:204) 648-158-00-5 Κ(cid:239)κ (ÆνθρÆκ(cid:222)(cid:240)Ø(cid:243)(cid:243)Æ) łÆµηλη(cid:139) ς θ(cid:229)ρµ(cid:239)κρÆ(cid:243)(cid:221)Æ, κÆ(cid:244)ρ(cid:192)µη υψηλη(cid:139) ς θ(cid:229)ρ- µ(cid:239)κρÆ(cid:243)(cid:221)Æς 648-159-00-0 140203-12-9 140203-13-0 140413-61-2 22. 1. 1999 EL Ε(cid:240)(cid:221)(cid:243)ηµη Ε(cid:230)ηµ(cid:229)ρ(cid:221)(cid:228)Æ (cid:244)ων Ευρω(cid:240)Æϊκω(cid:139) ν Κ(cid:239)Øν(cid:239)(cid:244)η(cid:139) (cid:244)ων C 18/47 ΑΙΤΙˆΛˆΓΙΚΗ ΕΚΘΕΣΗ ΤˆΥ ΣΥΜΒˆΥΛΙˆΥ I. ΕΙΣΑΓΩΓΗ 1. Σ(cid:244)Øς 8 ΙÆν(cid:239)υÆρ(cid:221)(cid:239)υ 1998, η Ε(cid:240)Ø(cid:244)ρ(cid:239)(cid:240)η(cid:139) υ(cid:240)(cid:229)(cid:139) (cid:226)Æλ(cid:229) (cid:243)(cid:244)(cid:239) Συµ(cid:226)(cid:239)υ(cid:139) λØ(cid:239) (cid:240)ρ(cid:222)(cid:244)Æ(cid:243)η, µ(cid:229) (cid:226)(cid:192)(cid:243)η (cid:244)(cid:239) (cid:192)ρθρ(cid:239) 100 Α (cid:244)ης (cid:243)υνθη(cid:139) κης ΕΚ, γØÆ (cid:244)ην (cid:244)ρ(cid:239)(cid:240)(cid:239)(cid:240)(cid:239)(cid:221)η(cid:243)η (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 76/769/ΕˆΚ (cid:244)(cid:239)υ Συµ(cid:226)(cid:239)υλ(cid:221)(cid:239)υ (cid:240)(cid:229)ρ(cid:221) (cid:240)ρ(cid:239)(cid:243)(cid:229)γγ(cid:221)(cid:243)(cid:229)ως (cid:244)ων ν(cid:239)µ(cid:239)θ(cid:229)(cid:243)Øω(cid:139) ν (cid:244)ων κρÆ(cid:244)ω(cid:139) ν µ(cid:229)λω(cid:139) ν (cid:240)(cid:239)υ Æ(cid:230)(cid:239)ρ(cid:239)υ(cid:139) ν (cid:240)(cid:229)ρØ(cid:239)ρØ(cid:243)µ(cid:239)υ(cid:139) ς (cid:244)ης κυκλ(cid:239)(cid:230)(cid:239)ρ(cid:221)Æς (cid:243)(cid:244)ην Æγ(cid:239)ρ(cid:192) κÆØ (cid:244)ης łρη(cid:139) (cid:243)ης µ(cid:229)ρØκω(cid:139) ν (cid:229)(cid:240)Øκ(cid:221)ν(cid:228)υνων (cid:239)υ(cid:243)Øω(cid:139) ν κÆØ (cid:240)ÆρÆ(cid:243)κ(cid:229)υÆ- (cid:243)µ(cid:192)(cid:244)ων. 2. Τ(cid:239) Ευρω(cid:240)Æϊκ(cid:222) Κ(cid:239)Øν(cid:239)(cid:226)(cid:239)υ(cid:139) λØ(cid:239) (cid:229)(cid:139) (cid:228)ω(cid:243)(cid:229) (cid:244)η γνω(cid:139) µη (cid:244)(cid:239)υ γØÆ (cid:244)ην (cid:240)ρ(cid:222)(cid:244)Æ(cid:243)η (cid:244)ης Ε(cid:240)Ø(cid:244)ρ(cid:239)(cid:240)η(cid:139) ς (cid:243)(cid:244)Øς 18 Φ(cid:229)(cid:226)ρ(cid:239)υÆρ(cid:221)(cid:239)υ 1998, (cid:229)γκρ(cid:221)ν(cid:239)ν(cid:244)(cid:192)ς (cid:244)ην łωρ(cid:221)ς (cid:244)ρ(cid:239)(cid:240)(cid:239)λ(cid:239)γ(cid:221)(cid:229)ς. Η ˆØκ(cid:239)ν(cid:239)µØκη(cid:139) κÆØ Κ(cid:239)ØνωνØκη(cid:139) Ε(cid:240)Ø(cid:244)ρ(cid:239)(cid:240)η(cid:139) (cid:229)(cid:139) (cid:228)ω(cid:243)(cid:229) (cid:244)η γνω(cid:139) µη (cid:244)ης (cid:243)(cid:244)Øς 29 Α(cid:240)ρØλ(cid:221)(cid:239)υ 1998. Τ(cid:239) Συµ(cid:226)(cid:239)υ(cid:139) λØ(cid:239) κÆθ(cid:222)ρØ(cid:243)(cid:229) (cid:244)ην κ(cid:239)Øνη(cid:139) θ(cid:229)(cid:139) (cid:243)η (cid:244)(cid:239)υ, (cid:243)υ(cid:139) µ(cid:230)ωνÆ µ(cid:229) (cid:244)(cid:239) (cid:192)ρθρ(cid:239) 189 Β (cid:244)ης (cid:243)υνθη(cid:139) κης, (cid:243)(cid:244)Øς 14 ∆(cid:229)κ(cid:229)µ(cid:226)ρ(cid:221)(cid:239)υ 1998. II. ΣΤˆ(cid:204)ˆΙ Η (cid:239)(cid:228)ηγ(cid:221)Æ 94/60/ΕΚ (cid:244)(cid:239)υ Ευρω(cid:240)Æϊκ(cid:239)υ(cid:139) Κ(cid:239)Øν(cid:239)(cid:226)(cid:239)υλ(cid:221)(cid:239)υ κÆØ (cid:244)(cid:239)υ Συµ(cid:226)(cid:239)υλ(cid:221)(cid:239)υ, γØÆ (cid:244)η (cid:228)(cid:229)(cid:139) κÆ(cid:244)η (cid:244)(cid:229)(cid:139) (cid:244)Æρ(cid:244)η (cid:244)ρ(cid:239)(cid:240)(cid:239)(cid:240)(cid:239)(cid:221)η(cid:243)η (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 76/769/ΕˆΚ (cid:240)(cid:229)ρ(cid:221) (cid:240)ρ(cid:239)(cid:243)(cid:229)γγ(cid:221)(cid:243)(cid:229)ως (cid:244)ων ν(cid:239)µ(cid:239)θ(cid:229)(cid:244)Øκω(cid:139) ν, κÆν(cid:239)νØ- (cid:243)(cid:244)Øκω(cid:139) ν κÆØ (cid:228)Ø(cid:239)Øκη(cid:244)Øκω(cid:139) ν (cid:228)ØÆ(cid:244)(cid:192)Œ(cid:229)ων (cid:244)ων κρÆ(cid:244)ω(cid:139) ν µ(cid:229)λω(cid:139) ν (cid:240)(cid:239)υ Æ(cid:230)(cid:239)ρ(cid:239)υ(cid:139) ν (cid:240)(cid:229)ρØ(cid:239)ρØ(cid:243)µ(cid:239)υ(cid:139) ς (cid:244)ης κυκλ(cid:239)(cid:230)(cid:239)ρ(cid:221)Æς (cid:243)(cid:244)ην Æγ(cid:239)ρ(cid:192) κÆØ łρη(cid:139) (cid:243)(cid:229)ως µ(cid:229)ρØκω(cid:139) ν (cid:229)(cid:240)Øκ(cid:221)ν(cid:228)υνων (cid:239)υ(cid:243)Øω(cid:139) ν κÆØ (cid:240)ÆρÆ(cid:243)κ(cid:229)υÆ(cid:243)µ(cid:192)(cid:244)ων, (cid:240)ρ(cid:222)(cid:243)θ(cid:229)(cid:243)(cid:229) (cid:229)(cid:139) νÆν κÆ(cid:244)(cid:192)λ(cid:239)γ(cid:239) (cid:239)υ(cid:243)Øω(cid:139) ν (cid:240)(cid:239)υ (cid:244)ÆŒØν(cid:239)µ(cid:239)υ(cid:139) ν(cid:244)ÆØ ως κÆρκØν(cid:239)γ(cid:222)ν(cid:229)ς, µ(cid:229)(cid:244)ÆλλÆŒØ(cid:239)γ(cid:222)ν(cid:229)ς η(cid:139) (cid:244)(cid:239)ŒØκ(cid:229)(cid:139) ς γØÆ (cid:244)ην ÆνÆ(cid:240)ÆρÆγωγη(cid:139) , κÆ(cid:244)ηγ(cid:239)ρ(cid:221)Æς 1 κÆØ 2 ((cid:239)υ(cid:243)(cid:221)(cid:229)ς κ/µ/Æ) (cid:243)(cid:244)(cid:239) (cid:240)Æρ(cid:192)ρ(cid:244)ηµÆ I (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 76/769/ΕˆΚ. Η (cid:239)(cid:228)ηγ(cid:221)Æ Æ(cid:240)Æγ(cid:239)ρ(cid:229)υ(cid:139) (cid:229)Ø (cid:244)η łρη(cid:243)Øµ(cid:239)(cid:240)(cid:239)(cid:221)η(cid:243)η (cid:244)ων (cid:239)υ(cid:243)Øω(cid:139) ν Æυ(cid:244)ω(cid:139) ν (cid:243)(cid:229) (cid:239)υ(cid:243)(cid:221)(cid:229)ς η(cid:139) (cid:240)ÆρÆ(cid:243)κ(cid:229)υ(cid:192)(cid:243)µÆ(cid:244)Æ (cid:240)(cid:239)υ κυκλ(cid:239)(cid:230)(cid:239)ρ(cid:239)υ(cid:139) ν (cid:243)(cid:244)ην Æγ(cid:239)ρ(cid:192) κÆØ (cid:228)ØÆ(cid:244)(cid:221)θ(cid:229)ν(cid:244)ÆØ (cid:243)(cid:244)(cid:239) κ(cid:239)Øν(cid:222). Η (cid:239)(cid:228)ηγ(cid:221)Æ 96/54/ΕΚ (cid:244)ης Ε(cid:240)Ø(cid:244)ρ(cid:239)(cid:240)η(cid:139) ς γØÆ (cid:244)ην 22η (cid:240)ρ(cid:239)(cid:243)Æρµ(cid:239)γη(cid:139) (cid:243)(cid:244)ην (cid:244)(cid:229)łνØκη(cid:139) (cid:240)ρ(cid:239)(cid:222)(cid:228)(cid:239) (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 67/548/ΕˆΚ, (cid:240)ρ(cid:222)(cid:243)θ(cid:229)(cid:243)(cid:229) 16 ν(cid:229)(cid:139) (cid:229)ς (cid:239)υ(cid:243)(cid:221)(cid:229)ς κ/µ/Æ (cid:243)(cid:244)(cid:239) (cid:240)Æρ(cid:192)ρ(cid:244)ηµÆ I (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 67/548/ΕˆΚ. ∆υν(cid:192)µ(cid:229)Ø (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 94/60/ΕΚ, η Ε(cid:240)Ø(cid:244)ρ(cid:239)(cid:240)η(cid:139) υ(cid:240)(cid:239)łρ(cid:229)(cid:239)υ(cid:139) (cid:244)ÆØ νÆ υ(cid:240)(cid:239)(cid:226)(cid:192)λ(cid:229)Ø (cid:243)(cid:244)(cid:239) Ευρω(cid:240)Æϊκ(cid:222) Κ(cid:239)Øν(cid:239)(cid:226)(cid:239)υ(cid:139) λØ(cid:239) κÆØ (cid:244)(cid:239) Συµ(cid:226)(cid:239)υ(cid:139) λØ(cid:239) µØÆ ν(cid:229)(cid:139) Æ (cid:240)ρ(cid:222)(cid:244)Æ(cid:243)η γØÆ (cid:244)ην (cid:240)ρ(cid:239)(cid:243)θη(cid:139) κη (cid:244)ων (cid:239)υ(cid:243)Øω(cid:139) ν (cid:240)(cid:239)υ (cid:240)ρ(cid:222)(cid:243)(cid:230)Æ(cid:244)Æ (cid:244)ÆŒØν(cid:239)µη(cid:139) θηκÆν κ/µ/Æ (cid:243)(cid:244)(cid:239) (cid:240)Æρ(cid:192)ρ(cid:244)ηµÆ I (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 76/769/ΕˆΚ, (cid:244)(cid:239) Æργ(cid:222)(cid:244)(cid:229)ρ(cid:239) (cid:229)(cid:139) ŒØ µη(cid:139) ν(cid:229)ς µ(cid:229)(cid:244)(cid:192) (cid:244)η (cid:228)ηµ(cid:239)(cid:243)(cid:221)(cid:229)υ(cid:243)η (cid:244)ης (cid:244)ÆŒØν(cid:222)µη(cid:243)η(cid:139) ς (cid:244)(cid:239)υς ως (cid:239)υ(cid:243)Øω(cid:139) ν κ/µ/Æ (κÆ(cid:244)ηγ(cid:239)ρ(cid:221)Æς 1 κÆØ 2) (cid:243)(cid:244)(cid:239) (cid:240)λÆ(cid:221)(cid:243)Ø(cid:239) (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 67/548/ΕˆΚ (cid:244)(cid:239)υ Συµ(cid:226)(cid:239)υλ(cid:221)(cid:239)υ. Η (cid:240)Æρ(cid:239)υ(cid:139) (cid:243)Æ (cid:240)ρ(cid:222)(cid:244)Æ(cid:243)η (cid:244)ρ(cid:239)(cid:240)(cid:239)(cid:240)(cid:239)(cid:221)η(cid:243)ης θÆ (cid:229)(cid:240)(cid:229)κ(cid:244)(cid:229)(cid:221)ν(cid:229)Ø (cid:244)(cid:239)ν κÆ(cid:244)(cid:192)λ(cid:239)γ(cid:239) (cid:244)ων (cid:239)υ(cid:243)Øω(cid:139) ν κ/µ/Æ (cid:240)(cid:239)υ Æ(cid:240)ÆρØθµ(cid:239)υ(cid:139) ν(cid:244)ÆØ (cid:243)(cid:244)(cid:239) (cid:240)Æρ(cid:192)ρ(cid:244)ηµÆ I (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 76/769/ΕˆΚ (cid:240)ρ(cid:239)(cid:243)θ(cid:229)(cid:139) (cid:244)(cid:239)ν(cid:244)Æς (cid:244)Øς (cid:239)υ(cid:243)(cid:221)(cid:229)ς (cid:240)(cid:239)υ (cid:244)ÆŒØν(cid:239)µ(cid:239)υ(cid:139) ν(cid:244)ÆØ ως κ/µ/Æ κÆ(cid:244)ηγ(cid:239)ρ(cid:221)Æς 1 η(cid:139) 2 (cid:243)(cid:244)ην 22η (cid:240)ρ(cid:239)(cid:243)Æρµ(cid:239)γη(cid:139) (cid:243)(cid:244)ην (cid:244)(cid:229)łνØκη(cid:139) (cid:240)ρ(cid:222)(cid:239)(cid:228)(cid:239) (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 67/548/ΕˆΚ. Συν(cid:229)(cid:240)ω(cid:139) ς, θÆ Æ(cid:240)Æγ(cid:239)ρ(cid:229)υθ(cid:229)(cid:221) η łρη(cid:243)Øµ(cid:239)(cid:240)(cid:239)(cid:221)η(cid:243)η (cid:222)λων Æυ(cid:244)ω(cid:139) ν (cid:244)ων (cid:239)υ(cid:243)Øω(cid:139) ν Æ(cid:240)(cid:222) (cid:244)(cid:239)υς κÆ(cid:244)ÆνÆλω(cid:244)(cid:229)(cid:139) ς. III. ΑΝΑΛΥΣΗ ΤΗΣ ΚˆΙΝΗΣ ΘΕΣΗΣ Τ(cid:239) Συµ(cid:226)(cid:239)υ(cid:139) λØ(cid:239) (cid:240)ρ(cid:222)(cid:243)θ(cid:229)(cid:243)(cid:229) (cid:243)(cid:244)ην (cid:240)ρ(cid:222)(cid:244)Æ(cid:243)η (cid:244)ης Ε(cid:240)Ø(cid:244)ρ(cid:239)(cid:240)η(cid:139) ς, µ(cid:229) (cid:244)η (cid:243)υνÆ(cid:221)ν(cid:229)(cid:243)η(cid:139) (cid:244)ης, (cid:244)(cid:239) (cid:192)ρθρ(cid:239) 2 (cid:244)ης κ(cid:239)Øνη(cid:139) ς θ(cid:229)(cid:139) (cid:243)ης, κÆθω(cid:139) ς κÆØ (cid:244)η (cid:243)ł(cid:229)(cid:244)Øκη(cid:139) µ(cid:229) Æυ(cid:244)(cid:222) ÆØ(cid:244)Ø(cid:239)λ(cid:239)γØκη(cid:139) (cid:243)κ(cid:229)(cid:139) ψη 8. Τ(cid:239) (cid:192)ρθρ(cid:239) Æυ(cid:244)(cid:222) Æ(cid:240)(cid:239)(cid:243)κ(cid:239)(cid:240)(cid:229)(cid:221) (cid:243)(cid:244)ην Æ(cid:240)Æλ(cid:239)Ø(cid:230)η(cid:139) (cid:240)(cid:229)(cid:139) ν(cid:244)(cid:229) (cid:239)υ(cid:243)Øω(cid:139) ν Æ(cid:240)(cid:222) (cid:244)(cid:239)ν κÆ(cid:244)(cid:192)λ(cid:239)γ(cid:239) (cid:244)(cid:239)υ (cid:240)ρ(cid:239)(cid:243)Æρ(cid:244)η(cid:139) µÆ- (cid:244)(cid:239)ς (cid:243)(cid:244)(cid:239) (cid:243)ηµ(cid:229)(cid:221)(cid:239) 29 (cid:244)(cid:239)υ (cid:240)ÆρÆρ(cid:244)η(cid:139) µÆ(cid:244)(cid:239)ς I (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 76/769/ΕˆΚ. ˆØ (cid:240)(cid:229)(cid:139) ν(cid:244)(cid:229) Æυ(cid:244)(cid:229)(cid:139) ς (cid:239)υ(cid:243)(cid:221)(cid:229)ς, κÆθω(cid:139) ς κÆØ (cid:244)ρ(cid:229)Øς Æκ(cid:222)µÆ, (cid:229)(cid:221)łÆν η(cid:139) (cid:228)η (cid:228)ØÆγρÆ(cid:230)(cid:229)(cid:221) Æ(cid:240)(cid:222) (cid:244)(cid:239) (cid:240)Æρ(cid:192)ρ(cid:244)ηµÆ I (cid:244)ης (cid:239)(cid:228)ηγ(cid:221)Æς 67/548/ΕˆΚ, (cid:228)(cid:229)(cid:228)(cid:239)µ(cid:229)(cid:139) ν(cid:239)υ (cid:222)(cid:244)Ø (cid:229)(cid:221)łÆν η(cid:139) (cid:228)η κÆλυ(cid:230)θ(cid:229)(cid:221) Æ(cid:240)(cid:222) (cid:192)λλ(cid:229)ς κÆ(cid:244)Æłωρη(cid:139) (cid:243)(cid:229)Øς η(cid:139) η (cid:244)ÆŒØν(cid:222)µη(cid:243)η(cid:139) (cid:244)(cid:239)υς ως κÆρκØν(cid:239)γ(cid:222)νων (cid:229)(cid:221)ł(cid:229) (cid:229)ν (cid:244)ω µ(cid:229)(cid:244)ÆŒυ(cid:139) Æρθ(cid:229)(cid:221). Συν(cid:229)(cid:240)ω(cid:139) ς, (cid:229)(cid:139) (cid:240)ρ(cid:229)(cid:240)(cid:229) (cid:229)(cid:240)(cid:221)(cid:243)ης νÆ Æ(cid:240)Æλ(cid:229)Ø(cid:230)θ(cid:239)υ(cid:139) ν Æ(cid:240)(cid:222) (cid:244)ην (cid:239)(cid:228)ηγ(cid:221)Æ 76/769/ΕˆΚ, (cid:229)(cid:240)’ (cid:229)υκÆØρ(cid:221)Æ (cid:244)ης (cid:240)Æρ(cid:239)υ(cid:139) (cid:243)Æς (cid:244)ρ(cid:239)(cid:240)(cid:239)(cid:240)(cid:239)(cid:221)η(cid:243)η(cid:139) ς (cid:244)ης